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Abstract
Congenital heart defects (CHDs) are associated with a number of genetic and environmental
risk factors affecting approximately 1% of newborns. Shroom3 is an actin binding and
microtubule organizing protein essential for neural tube closure in mouse, Xenopus and
chick. In Xenopus shroom3 expression is found within the forming heart and loss of activity
results in malformed hearts. In addition, SHROOM3 has recently been associated with
heterotaxy in a human patient. Mice homozygous for the Shroom3 gene trap die at birth due
to exencephaly and here, I provide evidence that the majority of these mice have CHDs,
including septal defects, semilunar valve abnormalities, decreased ventricle wall thickness
and functional deficits. I fully describe the expression pattern of Shroom3 in heart
development, demonstrating it is widely expressed throughout the myocardium. My study is
an initial step in characterizing the cell activities that drive cardiac morphogenesis and that
result in CHDs when disrupted.
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Chapter 1

1

Introduction

The heart is the first functional organ to develop in a vertebrate organism. Amongst the
vertebrates, heart development proceeds through a common pattern. Major landmarks
that are passed during cardiogenesis include specification of the heart cell precursors,
their movement and fusion at the midline to form a beating tubular heart, and later the
looping and ballooning of the tube to generate the future chambers that will continue to
mature into a fully competent organ (Harvey, 2002) (Fig. 1). Cardiac development is a
highly ordered process and slight perturbations have been shown to result in congenital
heart defects or complete cardiac developmental failures adding to the complexity of
studying its development (Bruneau, 2008; McCulley and Black, 2012; Teekakirikul et al.,
2013). In order to understand how these defects may manifest, it is important to
understand the morphologic milestones of cardiogenesis.

1.1 Specification of the Heart
In amniotes, the progenitor cells of the heart are first seen during gastrulation, adjacent to
the cranial progenitors of the patterning embryo (Garcia- Martinez and Schoenwolf,
1993; Kinder et al., 2001). Precursors are first induced from splanchnic mesodermal cells
of the lateral plate at the lateral margins of the head precursor zone – an area that
maintains bone morphogenetic protein (Bmp) expression and inhibits canonical Wnt
signaling (Harvey, 2002; Marvin et al., 2001; Schneider and Mercola, 2001). Following
induction, heart progenitors migrate through the node and down the primitive streak as an
established progenitor zone (Garcia- Martinez and Schoenwolf, 1993; Kinder et al.,
2001).
In mice, by E6.0, cardiac cells begin migrating craniolaterally through the primitive
streak forming the two bilateral heart fields (Schoenwolf and Garcia- Martinez, 1995;
Tam et al., 1997). Within vertebrates, cardiac specification of these heart fields has been
shown to require expression of the transcription factor, Mesp1. In Mesp1 knockout
animals, Mesp2 is up-regulated in a compensatory fashion, however, complete ablation of
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Figure 1. Illustration of representative stages of mammalian heart development.
From the left, the cardiac crescent (first image) shows specification of segments that are
later seen in the primitive linear heart tube (second image). During the looping of the
linear heart tube (third image), ballooning of the future chambers and segmentation
occurs to form the mature heart (fourth image). A: atrium; Ao: Aorta; AS: aortic sac;
AVV: atrioventricular valve; V: ventricle; CT: conotruncus; LA: left atrium; LV: left
ventricle; PA: pulmonary artery; RA: right atrium; RV: right ventricle. Figure adapted
from Srivastava and Olson, 2000.
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both isoforms results in an absence of cardiac mesoderm demonstrating its importance.
Furthermore, by mRNA injections into Xenopus, it was shown that Mesp1 was sufficient
to induce ectopic heart tissue formation (Bondue et al., 2008; Bondue and Blanpain,
2010; Costello et al., 2011; David et al., 2008; Kitajima et al., 2000; Saga et al., 2000).
The ability of Mesp1 to induce cardiac specification has been shown to be the result of a
down-regulation of pluripotency genes and an up-regulation of the genes that are
essential for the cardiac program including Gata4, Nkx2.5 and Mef2c (Bondue and
Blanpain, 2010).

1.2 Cardiac Crescent and Heart Tube
At E7.5 of mouse development, the bilateral heart fields containing specified cardiac
precursors begin migrating to the ventral midline and fuse, forming what is known as the
cardiac crescent (Fig. 1; Buckingham et al., 2005). During this movement, key cardiac
transcription factors essential for patterning the heart are expressed (Tam et al., 1997).
The underlying mechanism behind the bilateral fusion process remains to be fully
understood. Traditionally, it has been thought that active migration of the differentiating
cardiac mesoderm along the underlying endoderm results in the fusion at the midline
while only recently the endoderm was shown to provide an active contractile property
rather than the passive role it was previously believed to have (DeHaan, 1963; Linask and
Lash, 1986, Varner and Taber, 2012). In zebrafish, expression of Gata5 from the
endoderm has been shown to be required for heart field fusion with failure resulting in
cardia bifida (Reiter et al., 1999). In mouse, loss of Gata4 expression also results in
cardia bifida and it is the expression in the endoderm that is required for the cardiac
fusion (Kuo et al., 1997; Molkentin et al., 1997). It is speculated that Gata5 is the
functional ortholog of the mammalian Gata4 in the zebrafish (Reiter et al., 1999). These
results suggest that the endoderm has both passive and active roles in the formation of the
cardiac crescent by providing a medium for migration, supplying key secretory factors as
well as contracting beneath the mesoderm.
Cardiac crescent formation is heavily influenced by a variety of signaling cascades. Bmp
in conjunction with Fgf expression and Wnt antagonism have been shown to promote
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differentiation of the myocardium within the crescent and can promote myocardial
differentiation within non-cardiac mesoderm (Lough et al., 1996; Schneider and Mercola,
2001). Sources of these signals are spatially and temporally restricted in a manner
consistent with them playing a role in endogenous cardiac specification with expression
of Wnt from the neural tube and presence of Bmp antagonists from the axial tissue
restricting cardiac gene expression to the forming crescent (Goldstein and Fishman, 1998;
Tzahor and Lassar, 2001). Once established, a large cardiac program is activated that
includes expression of Gata4, Gata5, Gata6, Nkx2.5, Mef2b, Mef2c; Hand1, Hand2,
Tbx5 and Tbx20 (Bruneau et al., 1999; Harvey, 1996; Meins et al., 2000; Molkentin,
2000; Naya et al., 1999; Srivastava et al., 1995). However, not all these factors are
expressed ubiquitously. For example, expression of Gata6 is found in the furthermost
cells from the midline and is fated to become the conduction system (Davis et al., 2001).
These cell populations, expressing discrete combinations of factors, within the crescent
are the first sign of patterning within the developing heart.
Over the last decade, a concept that there are two populations of cells that give rise to the
myocardium has emerged and these populations have been termed the first and second
heart field. While the first heart field consists of the cells required to make the primitive
heart tube, identification of the second heart field has helped explain certain
discrepancies in cardiac development and congenital heart defects (Kelly et al., 2001;
Mjaatvedt et al., 2001; Waldo et al., 2001). In chick, the second heart field has been
identified as a distinct region of the pharyngeal mesoderm adjacent and posterior to the
cardiac crescent, where it has been shown to contribute to the outflow tract myocardium
(Mjaatvedt et al., 2001; Waldo et al., 2001). In mouse, a secondary population of
myocardial progenitors was identified by a lacZ transgene under the control of the Fgf10
promoter (Zaffran et al., 2004). Cells labeled by the lacZ transgene were identified in the
pharyngeal mesoderm and were later shown to contribute to the myocardium of the
outflow tract and right ventricle. This second heart field lies on either side of the cardiac
crescent and as morphogenesis of the heart ensues, changes position to the dorsal
mesocardium behind the fusing heart tube (Zaffran et al., 2004). The full contribution of
the second heart field myocardial progenitors in mouse was revealed by lineage tracing of
Isl1 expressing cells that showed contributions to all heart regions except the left
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ventricle of which the first heart field is responsible (Cai et al., 2003). Since then, second
heart field populations have been identified in both Xenopus and zebrafish (Brade et al.,
2007; de Pater et al., 2009) suggesting that the division of two populations of cardiac
progenitors is evolutionarily conserved. It has now been suggested that the both the
second and first heart field likely arise from a common progenitor but that the cells of the
second heart field stays in a progenitor like state longer than first heart field cells
(Bondue et al., 2011).
During the formation of the crescent, both bilateral fields of endocardium and
myocardium travel together to fuse with their counterpart at the ventral midline.
Concurrently, the myocardium secretes an ECM, commonly referred to as cardiac jelly,
which effectively separates the two layers. At the site of fusion, the endocardial sheets
fuse first and the myocardium follows in a process still not well characterized. The
cardiac crescent will go on to form the primitive heart tube (Kirby, 2002). To first
generate the tube, a trough forms. Trough formation occurs via an invagination of the
epithelial sheet in which the myocardium remains anchored to the coelomic walls at the
arterial and venous poles (Sizarov et al., 2011). Following invagination, the tube begins
to close dorsally closest to the developing spine and from there in a caudal and cranial
manner until it forms a completely fused myocardial tube interiorly lined with cardiac
jelly and endocardial cells (Argüello et al., 1975; DeRuiter et al., 1992; MorenoRodriguez et al., 2006).
The primitive heart tube is a functional organ capable of pumping blood in a
unidirectional manner. The bulk of the myocardium that makes up the primitive heart
tube has reduced proliferative capacity and is composed of the first heart field precursors
that terminally differentiate and eventually form the embryonic ventricle. The remainder
of the cardiogenic mesoderm, or the second heart field cells, remain in a more
undifferentiated state and contribute to tube elongation due to their higher proliferative
capacity and contributions to the inflow and outflow tracts, atria and the right ventricle
(Buckingham et al., 2005; Cai et al., 2003; Soufan et al., 2006; Zaffran et al., 2004).
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1.3 Heart Looping
Concomitant with heart tube lengthening, looping occurs. Dextral looping of the heart
tube is well conserved across the vertebrates and serves to bring the caudal end of the
tube to lay adjacent to the cranial end in a process referred to as convergence (Kirby,
2002). This event makes the heart the first organ in the embryo to exhibit left-right
asymmetry (Stalsberg, 1996).
In order for proper development to progress, symmetry breaking in the embryo is
essential. In mouse, this symmetry breaking takes place in the node at E7.5 (Nonaka et
al., 1998). Unidirectional flow of the extra-embryonic fluid is generated by rotational
movement of 9+0 monocilia that are found tilted within the node cavity (Nonaka et al.,
1998; Sulik et al., 1994). Nodal flow is active for only a few hours during development
until asymmetry is established with the asymmetric expression of Nodal. In order for this
to be achieved, monocilia are found at an angle on the cell surface to allow for directional
flow (Cartwright et al., 2004; Komatsu and Mishina, 2013; Lee and Anderson, 2008;
Nonaka et al., 1998; Nonaka et al., 2005; Okada et al., 2005). Similarly in zebrafish and
Xenopus, ciliary beating drives symmetry breaking at the Kupffer’s vesicle and
gastrocoel roof plate, respectively (Essner et al., 2005; Schweickert et al., 2007).
Although asymmetric expression of Nodal is conserved amongst the vertebrates, the use
of cilia is not. In chick, understanding how symmetry is broken has proven to be difficult
as cilia of the Hensen’s node are not essential for asymmetric Nodal expression (Essner et
al., 2002). Instead, deformation of the node by cell shape rearrangements establishes the
asymmetric expression program (Cui et al., 2009; Gros et al., 2009).
The transcription factor Pitx2 and signaling protein, Nodal are normally expressed in the
left lateral plate mesoderm and are necessary for the left-right asymmetry patterning in
the embryo. During fluid flow reversal experiments, in which an artificial flow was
introduced through the node, asymmetric expression of Pitx2 and Nodal was lost and
resulted in randomized cardiac looping directionality (Nonaka et al., 2002). Interestingly,
flectin was shown to be the first protein expressed in the myocardium in an asymmetric
pattern (Tsuda et al., 1996). Increased expression in the left heart wall correlated better
with cardiac looping direction than that of Pitx2 expression. For example, increased
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expression within the ECM of the right ventricle wall corresponded to leftward looping,
increased expression in the left ventricle wall corresponded to rightward looping and
equal or no expression resulted in an unlooped heart (Linask et al., 2002; Linask et al.,
2003; Tsuda et al., 1996; Tsuda et al., 1998). When cardiac jelly was removed leaving no
ECM, looping was still not disrupted as intracellular flectin showed similar correlation
with looping direction (Baldwin and Solursh, 1989).
However, it has been shown both in the past and recently that cardiac looping cannot be
solely explained by the upstream genetic program or the expression of flectin. Actin
organization and accumulation has been suggested to be a major player in cardiac looping
due to the architectural differences between the inner and outer myocardial layers (Itasaki
et al., 1991; Latacha et al., 2005; Manasek et al., 1972; Price et al., 1996; Shiraishi et al.,
1995). Actin bundle accumulations of the myofibrils on the right side at the caudal end of
the heart resulted in dextral looping while accumulations on the left side exhibited
leftward looping. Use of cytochalasin B to inhibit actin subunit association resulted in
unlooped hearts suggesting an important role for actin in the looping process in chick
(Itasaki et al., 1991). Similarly, the looping process in rat hearts showed distinct regional
and local myofibrillar patterns resembling the patterns seen in chick heart looping (Price
et al., 1996). Although poorly understood, cardiac looping appears to be an integrated
system of inputs coming from the ECM, intracellular properties and the asymmetric
growth and addition of differentiating cardiac progenitors.

1.4 Chamber Formation
Following the looping of the heart tube, chamber morphogenesis commences shaping the
heart into its mature form. Constrictions and bulging of the heart tube are the first
discernible demarcations of chamber formation (Kirby 2002). The heart tube was once
thought to contain all the components necessary to develop a complete heart. However,
with the recent finding of the role of the second heart field, this model has since then
been adjusted (Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001). Ventricles
are formed as derivatives from both sides of the cardiac primordia of the heart tube and
by its looping end up in a left-right configuration (Bartman and Hove, 2005; Campione et
al., 2001). However, addition of cells from the second heart field is necessary for

8

complete right ventricle formation, adding to the developmental differences between the
two ventricles (Cai et al., 2003). It has also been shown that the outer curvature of the
looping heart tube is where the proliferation largely occurs (Icardo and Fernandex-Teran
1987; Pasumarthi and Field, 2002; Peshkovsky et al., 2011). Atrial formation, however,
shows isomerization as they are derived from the left or right primordia along with input
from the second heart field (Cai et al., 2003; Campione et al., 2001). Mapping of the
signaling pathways required for chamber morphogenesis has been extensively studied.
Expression analysis has shown discrete regions of specific cardiac transcription factors
such as Hand1, Irx4, Irx 5, Nkx2.5, Gata4, Tbx2, Tbx3, Tbx5 and Tbx20 necessary to give
rise to functional chambers when expressed properly, both spatially and temporally (Rana
et al., 2013).
Defined spatially from the tubular heart, the ventricles are oriented by the dextral looping
of the heart tube bringing them into a left –right configuration (Bartman and Hove, 2005;
Campione et al., 2001). However, how the different morphologies between the two
ventricles are obtained is not fully understood although a number of differential gene
expressions have been found (Franco et al., 2006; Takeuchi et al., 2003; Vincentz et al.,
2011). During midgestation, myocardial thickening of the ventricle walls occurs and
cardiomyocyte protrusions into the luminal space of the outer curvature of the ventricles
gives rise to the trabecular myocardium (Sedmera et al., 2000). This trabecular growth
along the outer curvature of the primitive heart tube is needed for the expansion of the
future ventricle (de Boer et al., 2012; Moorman and Christoffels, 2003). By E9.5 in
mouse, extensive expansion of the trabecular ridge is initiated by active recruitment of
cardiomyocytes from the compact layer into the lumen as well as proliferation within the
trabecular myocardium. However, the proliferative capability of myocardial cells is
graded with highest capacity at the outside of the heart and less inwards suggesting that
cardiomyocyte recruitment is responsible for the bulk of the trabeculation network
(Icardo and Fernandex-Teran 1987; Pasumarthi and Field, 2002; Peshkovsky et al.,
2011). During this time, compaction of the trabecular myocardium strengthens the
integrity of the ventricle walls. By E14.5, the majority of the trabeculae are believed to
have been created and compacted and are suggested to facilitate oxygen and nutrient
exchange as well as to enhance the force generated by the embryonic heart muscle
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(Bartman and Hove 2005; Risebro and Riley, 2006; Sedmera et al., 2000; Taber, 1998).
Compaction of the trabeculae is not entirely understood, however trabeculae have been
shown to thicken at their base in order to assimilate into the compact layer of the
myocardium. Deficiencies in this process result in ventricle non-compaction which can
be fatal (Chen et al., 2009; Risebro and Riley, 2006).
Septation of the heart separates the forming organ into four distinct units when all the
respective septae fuse at the atrioventricular cushion (Kirby, 2002). In the atrial chambers
two septa form. The primary septum is considered the only true septum; composed of
mesenchyme contributed by the dorsal mesocardium while the secondary septum is
derived by a fold of the atrial myocardium (Kirby, 2002). Ventricular septation occurs at
the site of greatest convexity in the looped heart as a luminal protrusion that grows
towards the atrioventricular cushion and is completed by E14.5 in mouse (Anderson et
al., 2003). By E15.5 in mouse, the heart has achieved its mature morphologic
configuration and is left to deal with growth and the maturation of the cardiac valves
(Savolainen et al., 2009).

1.5 Congenital Heart Defects
Proper formation of the four-chambered heart is a complex process integrating growth
and differentiation and it is perhaps not surprising that errors in the process are relatively
common. It is suggested that approximately 1% of live births show some form of a
congenital heart defect making it the leading form of congenital disorders found in
newborns (Hoffman and Kaplan, 2002). The causes of these congenital heart defects are
largely unknown, although recent studies have demonstrated that a subset of the
population is genetically predisposed to heart defects, however this does not explain the
heterogeneity of cardiovascular defects (Hoffman and Kaplan, 2002; Teekakirikul et al.,
2013). In particular, mutations in key transcription factors or loss of specific signaling
pathways can potentially result in congenital heart defects or even complete failure to
develop a heart.
Our first understanding of monogenic mutations that affect cardiac development came
from experiments on the role of Nkx2.5 in the vertebrate heart. Nkx2.5 is a homeobox-
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containing transcription factor that is essential for the establishment of myocardial
lineages during development although it also plays a role in development of other organs
including the spleen and tongue (Bodmer et al., 1990; Prall et al., 2002). Expressed as the
earliest marker for the cardiac lineage, ablation of Nkx2.5 in mouse is embryonic lethal
and embryos exhibit cardiac looping defects and some loss of the cardiac gene program
(Lyons et al., 1995). Nkx2.5 was initial discovery in Drosophila resulted in complete
cardiac absence when lost and was thus named tinman in the fly (Bodmer, 1993; Lyons et
al., 1995). Studies in these animal models facilitated mapping studies in humans that
identified NKX2.5 as the first gene known to cause congenital heart defects when mutated
in humans (Schott et al., 1998).
Since then, a series of mutations in additional transcription factors have been
demonstrated to result in specific yet heterogeneous cardiac malformations (Bruneau,
2008; McCulley and Black, 2012; Teekakirikul et al., 2013). For example, dominant
mutations in GATA4 (Garg et al., 2003) and Tbx5 (Basson et al., 1997) result in a variety
of cardiac malformations ranging from septal defects to conduction problems. Although
identical mutations within different patients exist, the phenotypic presentation of the
cardiac malformations can vary. Not only have these transcription factor mutations been
associated with cardiac defects, but some present as discrete congenital abnormalities as
seen in humans with TBX5 mutations that cause Holt-Oram syndrome characterized by
both forelimb, conduction defects and cardiac malformations (Basson et al., 1997). The
heterogeneity of defects seen in these mutations - from cardiac malformations, structural
abnormalities and conduction defects – has added to the complexity of understanding
their roles in cardiac development.
Mutations in proteins that are not transcription factors have also been shown to cause
congenital heart defects. The planar cell polarity proteins, Dishevelled2 (Dvl2) and Van
goh-like2 (Vangl2), have been shown to affect heart morphogenesis when disrupted. The
planar cell polarity pathway is an intracellular program that aligns groups of cells.
In Dvl2 knockout mice, fifty percent of embryos have double outlet right ventricles,
transposition of the great arteries and/or persistent truncus arteriosis (Hamblet et al.,
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2002). Vangl2 deficiencies are studied using the naturally occurring mouse mutant, Looptail, in which all homozygotes for the mutant allele exhibit a double outlet right ventricle
as well as perimembranous ventricular septal defects and double sided aortic arches to
varying incidences (Henderson et al., 2001). Planar cell polarity is essential in
coordinating cell behavior in many systems (Zallen, 2007) but its role in heart
morphogenesis is not well understood. Furthermore, the ECM has been shown to
contribute to proper cardiac morphogenesis as the absence of fibronectin in the ECM
results in irregular adherens junctions in the precursor cells leading to abnormal integrity
due to a loss of the epithelial phenotype and maturation of the tissue which is necessary
for its migration to form the linear heart tube (Trinh and Stainier, 2004). Evidently, our
understanding of heart morphogenesis remains superficial as the gap in knowledge
between the transcription factors, polarity, ECM and the environment and their roles in
heart development remain to be filled.

1.6 Actomyosin Cytoskeleton
To begin understanding how abnormal morphologies of the heart might occur, we must
first understand the cellular machinery that dictates cell shape. Maintenance of both
apical-basal polarity and an intimate relationship with the actomyosin network is needed
to alter epithelial tissue architecture (Davidson, 2009; Knust and Bossinger; 2002).
Epithelial sheets are capable of exhibiting a wide variety of morphologic movements
such as invagination, involution and ingression. A delicate balance exists during tissue
morphogenesis as structural integrity and plasticity are in constant equilibrium
(Davidson, 2009).
The actomyosin cytoskeleton has two major constituents: nonmuscle myosin II and Factin. Transient and dynamic actomyosin activity exists in epithelia undergoing
morphogenesis and the accumulation of condensed actomyosin foci is correlated with
pulses of cell contractions which bring about morphological changes. Once
morphological changes are created they must be stabilized. Increased tissue stiffness, by
virtue of the actomyosin cytoskeleton and underlying microtubule and filament arrays,
stabilizes the morphology as development proceeds (Martin et al., 2009; Martin et al.,
2010; Rauzi et al., 2010).
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Nonmuscle myosin II is a major component of cytoskeletal network and is composed of
two heavy chains, two regulatory chains and two essential light chains (Ruff et al., 2001).
The N-terminus contains a globular head that permits actin binding and is the site of ATP
hydrolysis while the C-terminus mediates dimerization and filament formation (Ruff et
al., 2001). Actin binding by these motor proteins proceeds in a cyclical manner. First, the
globular head of the N-terminus couples to ATP and binds actin. Following the
hydrolysis of the ATP, a conformational change detaches the myosin motor, displacing
the actin filament as it re-associates with another ATP and binds the actin cytoskeleton
once again. This type of “walking” along the filament results in broad cell shape changes
depending on where the actin is anchored to in the cell (Rüegg et al., 2002). In mammals,
three different isoforms of nonmuscle myosin II exist (IIA, IIB and IIC) and these are
expressed in a wide range of tissues (Heissler and Manstein, 2013). These isoforms share
approximately 60-80% identity and although they show overlapping expression patterns,
are functionally distinct and of varying importance in different tissues (Heissler and
Manstein, 2013). For example, the heart expresses transcripts of all three isoforms;
however it is only ablation of nonmuscle myosin IIB that results in cardiovascular defects
(Ma and Adelstein, 2012).
Spatial and temporal regulation of actomyosin activity is essential in coordinating
epithelial morphogenesis and development and thus tight regulation of the motor protein
myosin II is required. This regulation is achieved by the phosphorylation of the
regulatory myosin light chains which increases its ATPase activity and thereby increasing
the actin "walking" of the motor protein (Somlyo and Somlyo, 2003). In epithelial cells,
ROCK is one of the primary kinases shown to phosphorylate and activate myosin II
(Amano et al., 1996).
ROCK is a major cytoskeleton regulator due to its interactions with key proteins, such as
myosin II, that are involved in cytoskeletal changes. It has been shown to be important
for a variety of intracellular processes including the formation of stress fibers and
disabling of their disassembly, cellular migration and contractility, and cell cycle
progression (Drechsel et al., 1997; Maekawa et al., 1999; Wang et al., 2009; Riento and
Ridley, 2003). In mouse, ROCK is found as two isoforms - ROCKI and ROCKII - and
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these isoforms share approximately 64% identity (Nakagawa et al., 1996). Expressed in a
wide range of tissues, ROCKI is distributed in the kidney, liver, lung, spleen and testis
while ROCKII is distributed mainly in the heart and brain (Nakagawa et al., 1996; Riento
and Ridley, 2003). Together, the actomyosin network and all its constituents are essential
for cell shape morphogenesis.

1.7 Apical Constriction and Elongation
Cell shape changes are required for proper heart development. Although we still do not
completely understand how and where these changes occur, we can appreciate that the
progression from the linear heart tube to the looped heart requires a great deal of changes
in cell morphology.
Tube formation is the result of remodeling polarized epithelia to surround a luminal space
or by polarizing precursors and creating a luminal space de novo (Bryant and Mostov,
2008; Chung and Andrew, 2008). A pre-existing polarity is thus essential for
tubulogenesis to commence (Hogan and Kolodziej, 2002). During initial tube formation,
the invagination of the epithelial sheet to form a trough is dependent on the nature of the
surrounding epithelia as well as the number and position of the cells that will undergo
shape change (Lubrasky and Krasnow, 2003). It is therefore essential to understand how
shape changes in epithelial cells are carried out to better gain insight as to how whole
tissues change morphology.
Apical constriction and apical-basal elongation are at the forefront of tubulogenesis and
epithelial morphogenesis (Hogan and Kolodziej, 2002). Apical constriction is essential in
development allowing for tissue bending, invagination, internalization of cells and tube
formation. In Xenopus and sea urchins, apical constriction drives the primary
invagination of cells during gastrulation to form the primitive gut (Hardin and Keller,
1988; Kimberly and Hardin, 1998). Apical constriction in C. elegans and Drosophila
drives cell ingression during gastrulation, internalization of mesoderm, dorsal closure,
eye development, formation of salivary glands and of the tracheal tubes (Costa et al.,
1994; Lee and Goldstein, 2003; Leptin and Grunewald, 1990; Sweeton et al., 1991;
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Tomlinson, 1985). Tubulogenesis that continues by wrapping is driven by apical
constriction (Smith and Schoenwolf, 1987; Smith and Schoenwolf, 1988).
Molecular events that are required for apical constriction include apical accumulation of
F-actin and activation of nonmuscle myosin II. Although upstream regulators vary
depending on the tissue and cell type, the central effectors, F-actin and myosin II motors,
remain (Lee and Harland, 2007). Two models for apical constriction exist - the "purse
string" and "ratchet" models. In the "purse string" model, it is suggested that apical
constriction is the result of a continuous constriction of the cell by the actomyosin
network (Baker and Schroeder, 1967; Rodriguez-Diaz et al., 2008). In live imaging of the
ventral furrow closure process in Drosophila, the "ratchet" model was proposed in which
asynchronous myosin contractions at the apical cortex pull adherens junctions inwards
thus achieving the apically constricted cell shape (Martin et al., 2009).
Apical-basal elongation is a microtubule driven process dependent on the nucleator, γtubulin (Gunawardane et al., 2000; Meads and Schroer 1995; Schoenwolf 1983;
Schoenwolf and Powers, 1987). In order for elongation to proceed, apical localization of
γ-tubulin is required to permit the formation of the parallel microtubule array that will
thicken the cell in an apical-basal manner. This localization of γ-tubulin is mediated by
Shroom3 in the neural tube and gut (Lee et al., 2007; Chung et al., 2010). Elongation
produces columnar cells, and although elongation is seen in many epithelial sheets that
then proceed to apically constrict; elongation is independent of apical constriction as
there are epithelia that thicken with no subsequent apical constriction (Hogan and
Kolodziej, 2002).
Wrapping is a process driven by apical constriction in which the polarized epithelium
invaginates and detaches from the adjacent epithelia to form tubes. This process requires
apical localization of ROCK which can be achieved by a variety of transcriptional events,
signaling cascades, as well as association with PDZ containing proteins such as Shroom3
(Dawes-Hoang et al., 2005; Haigo et al., 2003;; Hildebrand, 2005; Kölsch et al., 2007;
Nishimura and Takeichi, 2008; Sawyer et al., 2010). The apical accumulation of either
ROCK isoform leads to the activation of nonmuscle myosin II resulting in the contraction
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of the actomyosin cytoskeleton at sites near or at apical adherens junctions. An example
of wrapping is seen during neural tube closure where discrete populations of cells in the
epithelial sheet undergo apical constriction following generalized thickening of the sheet.
These wedge-forming cells are termed the median hinge point cells and the dorsal lateral
hinge point cells. First, apical constriction of the median hinge point cells results in the
initial trough formation or invagination. Following this movement, apical constriction of
the dorsal lateral hinge point cells results in the folding of the trough to meet at the
midline as a seamless tube (Colas and Schoenwolf, 2001; Smith and Schoenwolf, 1997).
The morphogenetic process that drives neural tube closure has been instrumental in
understanding the morphogenesis of other tubular organs and in establishing the role of
the actomyosin network in apical constriction and apical-basal elongation.

1.8 Shroom Family of Proteins
The Shroom protein family has been shown to play important roles in the morphogenesis
of epithelial cells across a wide range of tissues. These proteins are defined on the basis
of containing the Apx/Shroom (ASD) domain of which there are two. Since the finding
of Shroom3 (formerly Shroom), protein sequence analysis showed conservation of these
domains with two other previously characterized proteins - apical protein Xenopus (APX)
and apical protein Xenopus-like (APXL) resulting in the renaming of APX and APXL to
Shroom1 and Shroom2, respectively (Hagens et al., 2006a; Schiaffino et al., 1995; Staub
et al., 1992). Similarly, Shroom4, previously known as KIAA1202, was added to the
family on the basis of its domain structure (Hagens et al., 2006b). The two domains
present in this family are the central ASD1 and the C-terminal ASD2 (Hildebrand and
Soriano, 1999). While all members of the family contain an ASD domain, Shroom4 is the
only member lacking the ASD1 domain (Hagens et al., 2006b; Yoder and Hildebrand,
2007). Interestingly, Shroom1 expression has only been documented in Xenopus while
the remaining family members have been identified in other vertebrates and orthologues
are found in invertebrates, such as sea urchin and Drosophila (Dietz et al., 2006; Lee et
al., 2009; Yoder and Hildebrand, 2007).
Expression of the Shroom family members has been best studied in Xenopus. Shroom1
transcripts, as detected by in situ hybridization, are localized to the animal pole of
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unfertilized Xenopus eggs (Lee et al., 2009). Shroom1 mRNA is also detectable in the
deep layer of the neural plate, notochord, paraxial mesoderm of the somites, dorsal
cement gland, otic placode and the pronephric tubes and ducts (Lee et al., 2009).
Shroom2 transcripts are also enriched at the animal pole of unfertilized Xenopus eggs
(Lee et al., 2009). Shroom2 is expressed throughout the deep layer of the neural plate,
forebrain, midbrain, eye cup, otic placode, kidney, notochord and retinal pigment
epithelium (Lee et al., 2009). Shroom4 expression is found in the somites, ventral
mesodermal tissue of the trunk, eye cup, boundary cells of the cement gland, pronephric
duct and tubules, otic vesicle, olfactory placode and the presumptive mouth (Lee et al.,
2009). Shroom3 expression is first detected at the mid-blastula transition stage in
Xenopus with expression in the superficial layer of the neural plate, the otic, lateral line
and olfactory placodes, dorsal cement gland, proctodeum, forebrain, midbrain, posterior
neural tube, kidney and heart (Lee et al., 2009).
Expressed in both overlapping and unique tissue types, Shroom proteins have all been
shown to regulate the cytoskeletal network and promote morphogenesis of the tissue in
which they function (Dietz et al., 2006; Hildebrand and Soriano, 1999; Yoder and
Hildebrand, 2007; Zuckerman et al., 1999).

1.9
Shroom3 is an actin binding protein shown to be necessary for proper neural tube
formation in Xenopus, mouse and chick. It was first identified in a gene trap assay where
mutant mice showed failure of neural tube closure (Haigo et al., 2003; Hildebrand and
Soriano, 1999). Another mouse line with a missense mutation in the ROCK binding
domain, ASD2, has also demonstrated the requirement for Shroom3 as these mice also
showed failure of neural tube closure (Marean et al., 2011). Originally called Shroom
because the brains of mutants mushroom out, it was renamed Shroom3 when the
nomenclature of the protein family was rationalized (Hagens et al., 2006). Like the rest of
the family members, Shroom3 has been implicated in the morphogenesis of many
epithelial tissues. In the Shroom3 gene trap mouse line, mice homozygous for the gene
trap exhibit completely penetrant exencephaly and acrania contributing to perinatal
lethality, however, until birth, Mendelian ratios for the genotypes do not appear to be
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disturbed. To a lesser extent, spina bifida, ventral closure failure and facial clefting are
also exhibited by the mice. Interestingly, around 8% of heterozygotes show the
exencephaly phenotype, suggesting a dosage sensitive response (Hildebrand and Soriano,
1999). In mouse, two isoforms of Shroom3 have been identified. Both contain the ASD1
and ASD2 domain as well as a putative proline rich EVH1 domain located between the
two ASD domains (Hildebrand and Soriano, 1999) but the shorter isoform lacks the PDZ
domain at the amino terminus (Fig. 2). Both isoforms have been shown to induce apical
constriction as well as apical-basal elongation suggesting that the N-terminal PDZ
domain is not essential for those functions of Shroom3 (Haigo et al., 2003)

1.10 Shroom3 Morphogenetic Roles
The role for Shroom3 in development that has been best characterized is its involvement
in neural tube closure where its ablation results in exencephaly (Hildebrand and Soriano,
1999). Since our understanding of neural tube closure is far more expansive than that of
heart tube closure, I hypothesized that Shroom3’s role in the neural tube might potentially
shed light on heart tube formation. In MDCK cells, it was shown that both the long and
short isoforms of Shroom3 are capable of inducing apical constriction and co-localizing
with β-catenin and ZO-1 at the adherens junctions (Haigo et al., 2003). However,
Shroom3 function in polarized cells has shown that its known activities are restricted to
redistribution of intracellular components rather than induction of expression of other
genes (Fig. 3) (Haigo et al., 2003). Interactions with its domains have been shown to be
modular, with the ASD1 domain capable of binding F-actin and the ASD2 domain shown
to interact with ROCK (Haigo et al., 2003; Nishimura and Takeichi, 2008). A number of
Shroom3 dependent effectors have been found including the Ena/VASP, myosin II,
ROCKI/II, F-actin and γ-tubulin. However, Shroom3 has been found to only directly bind
ROCK and F-actin (Chung et al., 2010; Clark et al., 2012; Dickson et al., 2010; Ernst et
al., 2012; Grosse et al., 2011; Haigo et al., 2003; Hildebrand, 2005; Hildebrand and
Soriano, 1999; Lee et al., 2007; Plageman et al., 2010; Plageman et al., 2011a; Plageman
et al., 2011b; Nishimura and Takeichi, 2008; Taylor et al., 2008 ).
In the neural tube, loss of Shroom3 results in loss of apical accumulation of F-actin at the
median and dorsal lateral hinge-point cells of the neural epithelia sheet; discrete
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Figure 2. Shroom3 is evolutionarily conserved. Shroom3 is found in a wide range of
organisms such as humans (h), mouse (m) and Xenopus (x). In mouse, two functional
isoforms exist and can induce apical constriction as well as apical-basal elongation
suggesting that the N-terminal PDZ domain is not essential for those functions of
Shroom3. Shroom family members are grouped by the presence of at least one ASD
domain. ASD1 domain has been shown to bind F-actin and the ASD2 domain to bind
ROCK. AA: amino acid; ASD1: Apx⁄Shroom domain 1; ASD2: Apx⁄Shroom domain 2;
PDZ: PSD95⁄Dlg1⁄ZO-1.
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Figure 3. Functional schematic of known Shroom3 functions. Shroom3 is capable
of promoting cell shape changes on already polarized epithelia by redistributing
present intracellular components. Two independent functions have been characterized.
Apical constriction is achieved by Shroom3 (orange) dependent apical localization of
actin (red) and ROCK (purple) in which the latter phosphorylates nonmuscle myosin
II (NMII) (green) promoting apical constriction. Apical-basal elongation is achieved
by Shroom3 dependent apical localization of γ-tubulin to allow for the expansion of
parallel microtubule arrays (green). In some epithelial tissues, both apical-basal
elongation and apical constriction mediated by Shroom3 is observed.
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populations of cells responsible for the invagination and tubular morphogenesis of the
sheet, respectively. The loss of apical F-actin results in failure to apically constrict and
form the wedge shape needed to morph the epithelial sheet (Hildebrand and Soriano,
1999). In the neural tube, apical constriction was shown to be ROCKI dependent
whereby the ASD2 domain would recruit ROCKI to the apical junctions allowing it to
phosphorylate and activate the myosin regulatory light chain promoting constriction of
the actomyosin network (Nishimura and Takeichi, 2008). However, it is important to note
that the Shroom3-ROCK complex was not sufficient to induce phosphorylation of the
myosin regulatory light chain as Shroom3, ROCK and myosin II positive cells did not
always have phosphorylated myosin present (Nishimura and Takeichi, 2008). During
neural tube closure, a thickening of the neuroepithelia is required. Shroom3 is required
for the thickening as its loss resulted in failure of apically localized γ-tubulin and apicalbasal elongation of the neuroepithelia (Lee et al., 2007).
Shroom3 also plays a role in other neurodevelopmental processes. In axonal
morphogenesis, Shroom3 was found to regulate axon process outgrowth using F-actin in
a ROCK-myosin IIA dependent manner via its interactions with the scaffold protein,
POSH (Dickson et al., 2010; Taylor et al., 2008). In zebrafish, formation of the neuronal
sensory organs called neuromasts also requires Shroom3. It was found that Shroom3, in a
ROCK dependent manner, is required for the assembly of the apically constricted rosette
structures that mature into neuromasts, but not for their maintenance. In this system,
FGFR signaling was found to be necessary and sufficient for Shroom3 expression in the
posterior lateral line primordium in which the neuromasts form (Ernst et al., 2012).
Lens pit invagination in mouse, Xenopus and chick has also been shown to require
Shroom3 (Plageman et al., 2010). This invagination process was shown to be ROCK
dependent whereby apically localized RhoA was capable of inducing apical constriction
by directing Shroom3 localization to the apical cortex where it functions via ROCK
activity (Plageman et al., 2011a). Shroom3 was found to redistribute F-actin, nonmuscle
myosinII, Vasp and γ-tubulin apically and is transcriptionally regulated by Pax6 in the
developing lens (Plageman et al., 2010). In the retinal neuropithelia of zebrafish,
Shroom3 loss resulted in an increased apical domain size of the neuroepithelial cells,
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reduced neurogenesis and increased Notch activity which is known to maintain neural
progenitors and block neurogenesis. This phenotype suggests a role in the differentiation
and maturation of the retinal epithelium that is apical constriction dependent (Clark et al.,
2012).
In Xenopus, dominant-negative shroom3 mRNA injections resulted in improperly
elongated and coiled gut tubes, and an overall decrease in thickened epithelia due to
failure of apically localized γ-tubulin (Chung et al., 2010). Within the developing gut
tube, shroom3 was found to be a direct transcriptional target of Pitx proteins (Pitx1,
Pitx2, and Pitx3) (Chung et al., 2010). This requirement was later found in mouse to be
essential for the smooth apical surface of emerging villi (Grosse et al., 2011). Shroom3
function in the gut was shown to require cooperation between N-cadherin and Shroom3
to affect cellular morphogenesis and control the tilting of the dorsal mesentery by
regulating F-actin and nonmuscle myosin II (Plageman et al., 2011b).
In the kidney, several genome wide association studies have shown a SNP associated
with SHROOM3 in patients with albumineria (Ellis et al., 2012), chronic kidney disease
by eGFR function (Bӧger et al., 2011; Bӧger and Heid, 2011; Kӧttgen et al., 2009;
Kӧttgen, 2010; Kӧttgen et al., 2010), hypomagnesia (Meyer et al., 2010), Type II diabetes
(Deshmukh et al., 2013) and hypertension (Simino et al., 2012). However, no biological
data to date has been shown to support these correlations.
Overall, the roles of Shroom3 in tissue morphogenesis remain centralized around its
ability to confer apical constriction and/or apical-basal elongation in the epithelia where it
is active. Its localization and expression appears to be tightly regulated in space and time,
suggesting varied and important roles in development.

1.11 Shroom3 Role in Cardiogenesis
Although expression patterns of the Shroom protein family show overlap, Shroom3 is the
only member of the family normally expressed in the heart (Lee et al., 2009). In Xenopus,
shroom3 is expressed in the heart region before genes associated with differentiation are
expressed (Drysdale et al., 1994; Grover, 2009). Using morpholino and dominant

22

negative shroom3 mRNA injections, a requirement for shroom3 was shown for
thickening of the myocardium and the formation of flexion points where the presumptive
myocardium and pericardium meet which suggests a role in heart tube closure (Fig. 4)
(Grover, 2009). Differentiation of the myocardium was unaffected with loss of shroom3.
However, heart tubes did eventually close in shroom3 deficient Xenopus embryos
although heart tube closure was delayed and displayed abnormal heart morphologies.
Expression of shroom3 persisted beyond tube formation, suggesting there may be a
potential role in the later cardiomorphogenetic events such as looping and chamber
formation. Indeed, embryos lacking functional shroom3 displayed improper looping of
the heart as well as pericardial edema, a known indicator of poor heart function (Grover,
2009).
Using whole exome sequencing, a recessive missense mutation in SHROOM3 in a patient
with heterotaxy was recently found (Tariq et al., 2011). Heterotaxy is the abnormal
distribution in organ position within the chest and⁄or abdomen. Mixing of organ
asymmetries (situs ambiguous) leads to severe complications that usually result in cardiac
defects such as transposition of the great arteries, atrial and ventricular septal defects,
double outlet right ventricle and pulmonary atresia and stenosis (Belmont et al., 2004).
This further suggests a potential linkage between Shroom3 and heart morphogenesis and
importantly, a potential role in human congenital heart defects.
While the results from Xenopus suggest a role for shroom3 in cardiogenesis, it is then
somewhat surprising that the mouse embryo survives until birth because severe cardiac
defects, as seen in Xenopus, would be predicted to result in early embryonic lethality in
mouse. Therefore, we felt that it was important to determine if there were defects in the
heart of mice lacking functional Shroom3.

1.12 Purpose of Thesis and Hypothesis
This thesis attempts to understand the morphogenetic pathways that regulate cardiac
morphogenesis and result in cardiac defects when disrupted. Since the initial
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Figure 4. Heart tube formation is delayed with loss of shroom3. In order to study
shroom3 function in the forming heart tube in Xenopus, shroom3 morpholino and
dominant negative mRNA were injected into one cell stage embryos and raised to stage
32 when heart tube closure is occurring. Using whole-mount in situ hybridization to
cardiac troponin I, the forming heart tube can be visualized from the ventral side of
embryos (A-E). The gap between the cement gland and forming heart tube is larger in
morpholino (C) and dominant negative (E) mRNA injected embryos when compared to
control embryos. Flexion points (green arrows) seen in transverse sections of uninjected
and control morpholino injected embryos (F&G&I) are lost in shroom3 morpholino and
dominant negative mRNA injected embryos indicating a delay in heart tube closure
(H&J). Adapted from Grover (2009).
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characterization of the tinman (Nkx2.5) knockout in heart development (Bodmer, 1993;
Lyons et al., 1995), our knowledge and understanding of cardiac malformations has not
been able to completely explain how genetic mutations in transcription factors results in
defects in morphology. The planar cell polarity pathway has been implicated in
congenital heart defects but defects in that pathway also do not explain the variety of
cardiac defects that can occur.
I wished to examine the earliest events of cardiac morphogenesis but as heart tube closure
is an early event in mammals, our understanding of the process is relatively weak
(Harvey, 20002). And so I used the well-characterized process of neural tube closure as a
model to better understand heart tube closure. Shroom3 was first characterized in its
essential role in neural tube closure in mouse and is the only Shroom protein found in the
heart (Hildebrand and Soriano, 1999; Lee et al., 2009). In Xenopus, shroom3 morpholino
and dominant negative mRNA injected embryos display open neural tubes, delay in heart
tube closure and abnormal heart tube looping suggesting that unlike in the neural tube it
was not essential for heart tube closure but still required for normal heart development
(Grover, 2009). Due to the severity of the cardiac malformations in shroom3 depleted
Xenopus embryos, we did not expect that loss of Shroom3 in mouse to be as severe on
cardiogenesis as embryos survive to term but die due to the exencephaly phenotype
(Hildebrand and Soriano, 1999). However, there is no information on whether these
embryos have cardiovascular malformations. With the recent association of a missense
mutation in SHROOM3 in a human patient with heterotaxy (Tariq et al., 2011) this
question becomes even more urgent. Thus, I hypothesized that the Shroom3 gene trap
mouse line would show congenital heart defects.
In this thesis, I add on to our growing understanding of heart development suggesting that
the loss of the morphogenetic protein, Shroom3, results in congenital heart defects in
mouse such as ventricular septal defects, semilunar valve defects and decreased left
ventricle wall thickness. My results suggest that in order to fully understand the
mechanisms underlying congenital heart defects, the integration of already defined
pathways studied in isolation, especially those involved in tissue morphogenesis and
organization, is essential.

25

Chapter 2

2

Materials and Methods

2.1 Shroom3 gene trap mice
The Shroom3 gene trap mice (B6.129S4-Shroom3Gt(ROSA53)Sor/J) were purchased
from The Jackson Laboratory and maintained on a C57BL⁄6 background. Generation of
the mutant line was by a gene trap assay using the cassette SaβgalCrepA – containing the
adenovirus splice acceptor (Sa) (Friedrich and Soriano, 1991), a bifunctional gene
encoding a fusion between β-galactosidase (β-gal) and Cre recombinase and an MC1
polyadenylation (pA) sequence (Thomas and Capecchi, 1987) as described in Hildebrand
and Soriano (1999). Throughout the remainder of the thesis, we will refer to the mutant
allele as Gt.

2.2 Embryo collection
Timed pregnant dams were used in this study for all investigations of mouse embryos.
Vaginal plug presence in a morning check following heterozygous mating crossings was
referred to as E0.5 (embryonic day 0.5). Due to natural variation in ovulation and
conception, Theiler staging was also utilized to confirm the age of mouse embryos
(Theiler, 1972; Theiler, 1989). Pregnant dams were euthanized using CO2 and embryos
dissected out into cold PBS and processed further depending on the nature of the
experiment. All experiments were approved by the Animal Care Committee at Western
University Canada (Protocol #015-2011) and mice handled according to regulations by
the Canadian Council on Animal Care (CCAC).
Female Xenopus laevis frogs were injected in the thigh muscle with 700 IU of human
chorionic gonadotropin (Sigma) to induce ovulation overnight. Frogs were squeezed the
following morning to retrieve eggs that were then fertilized in vitro using minced testis in
80% Steinberg’s Solution. Following fertilization, embryos were de-jellied using 2.5%
cysteine (pH 8.0) and cultured in 20% Steinberg’s Solution. Embryos were staged
according to the Nieuwkoop and Faber staging table (Nieuwkoop and Faber, 1995).
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2.3 Genotyping
The genotypes of adults and embryos were determined using a polymerase chain reaction
(PCR) from tail clip or limb bud genomic DNA, respectively. Tissues were lysed
overnight at 55°C in tissue lysis buffer (100mM Tris-Cl pH 8.5, 200mM NaCl, 5mM
EDTA pH 8.0, 0.2% SDS (w/v) in dH2O) containing 100 µg/ml Proteinase K and the
genomic DNA was subsequently isolated by phenol/chloroform extraction. To detect the
wild-type Shroom3 allele, PCR was performed using primer pair F11: 5’GGTGACTGAGGAGTAGAGTCC -3’ and R4: 5’GCAACCACATGGTGGGAGACAAGC -3’. To detect the mutant allele in mice
heterozygous and homozygous for the gene trap insertion, the primer R1: 5’GAGTTTGTGCTCAACCGCGAGC -3’ was used in conjunction with primer F11. PCR
cycling parameter were 95°C for 1 minute, 65°C for 1 minute and 72°C for 1 minute for
35 cycles. The expected amplicon size for the wild-type allele (F11 & R4) is 1000 bp.
The expected size for the gene-trap allele amplicon (F11 & R1) is 1500 bp. Presence of
the mutant allele was further confirmed by amplifying the lacZ insert using the FlacZ: 5’GTTGCAGTGCACGGCAGATACACTTGCTGA- 3’ and RlacZ: 5’GCCACTGGTGTGGGCCATAATTCAATTCGC- 3’. PCR cycling parameters were
94°C for 30 seconds, 60°C for 30 seconds and 72°C for 1 minute for 35 cycles. The
expected amplicon size for the lacZ insert is 389 bp.

2.4 Whole Mount X-gal Staining and Clearing
Whole mount X-gal staining of the heart was performed on whole embryos (E7.5-E13.5)
or excised hearts of mice E14.5 and older. Heterozygous and wild-type samples were
stained in parallel. Samples were washed in cold PBS and fixed for 20 minutes to 2 hours
depending on the specimen thickness and then washed in PBST (PBS with 1% Triton-X)
at room temperature for an hour and again in fresh PBST overnight at 4°C for thicker
samples or those with excess blood remaining in the heart. Next, samples were put into
X-gal staining solution (0.5mg/ml X-Gal in DMF, 400µM potassium ferricyanide,
400µM potassium ferrocyanide, 2mM MgCl2) in PBST and left to stain at 37°C overnight
or until staining was visible. Samples were then washed twice in PBS and post fixed in
4% PFA (100mM Hepes, 10mM NaCl) in dH2O for 2 hours at room temperature to
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preserve staining. Samples were then cleared as described in (Schatz et al., 2005) with
minor modifications. Instead of clearing in 20%, 50%, 80% and 100% glycerol (v/v) with
1% KOH (w/v) in PBS for 4-7 days each, samples were cleared in scintillation vials for
one day each in 20% and 50% glycerol (v/v) with 1% KOH (w/v) in PBS with gentle
shaking at room temperature. Then, samples were cleared for 2-3 days in 80% glycerol
(v/v) with 1% KOH (w/v) in PBS at 37°C and again at 100% glycerol (v/v) with 1%
KOH (w/v) in PBS at room temperature until desired translucencies were achieved.
Samples were moved to a petri dish of fresh 100% glycerol for imaging. All samples
were visualized on Leica MZ12 dissecting microscope and whole mount images were
captured using Northern Eclipse software (Empix Imaging; Mississauga, ON, Canada).

2.5 Xenopus Treatments
Xenopus laevis embryos were immersed at stage 26 in 100µM (-) - blebbistatin
(Calbiochem), 100µM (+) -blebbistatin (Calbiochem), 20µM Rockout (EMD) or 10µM Y27632 (Sigma) in 20% Steinberg’s Solution. The dose of inhibitor was based on previous
investigations in our lab using the ROCK inhibitor Y-27632 and from investigations in
Xenopus using the myosin II inhibitor blebbistatin (Grover, 2009; Lee and Harland,
2007). The ideal dosage of Rockout, another ROCK inhibitor, was found by a doseresponse curve. The vehicle control used for all treatments was dimethylsulfoxide
(DMSO) in 20% Steinberg’s solution, In addition, (+) –blebbistatin, an inactive
enantiomer, served as a control for (-) – blebbistatin treatments. Embryos were fixed at
stage 32 or 36 in MEMPFA (4% PFA in dH2O, 1mM MgSO4, 100mM Mops pH 7.5,
2mM EGTA pH 8.0) for 2 hours at room temperature and transferred to 100% cold
methanol for storage until the in situ hybridization assay was performed.

2.6 Whole Mount in situ Hybridization
Whole mount in situ hybridizations were performed according to (Harland, 1991) with
minor modifications (Collop et al., 2006). The following additions were added: Trisbuffered saline (TBS) was used instead of phosphate-buffered saline (PBS); blocking was
done in Tris buffered saline with 20% heat treated sheep serum; the Proteinase K and
RNase A steps were omitted; and the 0.2x SSC washes were increased to 1 hour and the
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frequency of washes following antibody incubation were increased. An antisense
digoxygenin-labelled RNA probe for cardiac troponin I (Drysdale and Crawford, 1994)
was used to stain the differentiated myocardium. BM Purple (Roche Diagnostics) was
used as the alkaline phosphatase substrate and embryos were post fixed for 20 minutes in
MEMPFA before bleaching endogenous pigment in a bleaching solution (1% hydrogen
peroxide, 50% formamide, and 0.5% SSC) for several hours after staining. Heart tube
morphologies were revealed by imaging whole embryos from the ventral side and/or
razor sectioning through the stained embryos at the level of the forming heart in order to
view the cross sectional morphology. Embryos were visualized on a Leica MZ12
dissecting microscope and images were captured using Northern Eclipse software (Empix
Imaging; Mississauga, ON, Canada).

2.7 Cryosectioning
Embryos were fixed with 4% PFA in buffer containing100mM Hepes and 10mM NaCl,
saturated with 30% sucrose in PBS overnight at 4°C, and embedded in Tissue-Tek
CRYO-OCT (Fisher Scientific). Serial sections (10µm) were cut using a Leica 3050 S
motorized cryostat, mounted on Superfrost Plus microscope slides (VWR) and dried on a
37°C slide warmer for at least 1 hour. Slides were stored at -80°C prior to antibody
staining (Fagotto and Brown, 2008).

2.8 Paraffin Sectioning
Embryos were fixed overnight in 4% PFA in buffer containing 100mM Hepes and 10mM
NaCl at 4°C. Processing for wax embedding is in accordance to the protocol described in
Zeller (2001) with minor modifications. Embryos were dehydrated in graded ethanol
series for 10-20 minutes (70%, 80% and 100% ethanol) and cleared in xylene for 20
minutes. Fresh xylene was added for another 10 minutes and replaced with a preheated
xylene:wax (1:1) mixture at 65°C for 1 hour. The solution was replaced with fresh wax
for 1 hour and changed again to fresh wax for anywhere between 1 hour to overnight at
65°C, depending on the size and thickness of the specimen. Embryos were placed and
oriented in their molds with fresh wax for at least 30 minutes at 65°C to prevent
differential cooling when removed and cooled at room temperature overnight. Both
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sagittal and transverse sections were made using an AO Spencer 820 Microtome.
Sections of 5µm thickness (or 10µm for X-gal stained samples) were placed on
albumin:glycerin (1:1) coated slides covered in water and dried on a slide warmer at 37°C
overnight. Standard CAT hematoxylin and Eosin Y staining was performed (omitted for
X-gal stained sections) and coverslipped using Permount Mounting Medium (Thermo
Scientific). Slides were visualized on a DAS Mikroskop Leitz DMRB high-power
microscope and imaged by Image ProPlus.

2.9 Immunofluorescence
Immunofluorescence was performed according to Fagotto and Brown (2008) on
cryosections and antigen retrieved paraffin sections, however use of 0.2% Eriochrome
black was omitted. Antigen retrieval on deparaffinized paraffin sections was performed
in a 95°C water bath in sodium citrate buffer (10mM sodium citrate, 0.1% Triton-X, pH
6.0) for 25 minutes prior to the standard immunofluorescence protocol described in
Fagotto and Brown (2008). Primary antibodies used include rabbit polyclonal antibody to
nonmuscle myosin heavy chain IIB (1:100 dilution; Covance), mouse monoclonal
antibody to β-tubulin (1:200; Sigma-Aldrich), rabbit polyclonal antibody to aPKCζ (1:50;
Santa Cruz) and rabbit monoclonal antibody to phosphorylated histone H3 (1:500; Cell
Signaling). Primary antibodies were detected with Alexa Fluor 488/594 goat-anti-rabbit
or goat-anti-mouse IgG secondary antibodies (1:250 dilution; Molecular Probes). Control
slides contained no primary antibody and were incubated with only secondary antibody.
Wheat germ agglutinin Alexa Fluor 594 conjugate (5µg/ml; Invitrogen) and Oregon
Green Phalloidin 488 conjugate (5µg/ml; Invitrogen) were also used to visualize
myocardial cell borders and filamentous actin, respectively. Coverslipping was
performed using PermaFluor Aqueous Mounting Medium (Thermo Scientific) after
which slides were stored in the dark at 4°C. Slides were visualized on a Zeiss Axio
Imager Z1 and imaged by AxioVision 4.7.1.

2.10 Assessment of congenital heart defects
Sequential transverse sections (5µm) of paraffin embedded samples were cut and stained
with CAT hematoxylin and Eosin Y staining and examined by light microscopy.
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Ventricular septal defects (VSDs) were counted when a break in the ventricular septum
was found in histological section. Septal defects were analyzed by light microscopy for
intact endocardial lining to ensure defects seen were not the result of tissue tearing.
Membranous VSDs were classified as those found within the top third of transversely
sectioned hearts when all four chambers are visible in section. Muscular VSDs were
counted when atria were no longer found in section and the defect appeared to be
localized to the thicker, muscular portion of the ventricular septum (Minette and Sahn,
2006). Thick pulmonary valves and malformed aortic valves were comparable to the
abnormalities seen in the ADAM17 knockout mouse that exhibits semilunar valve defects
and was therefore used as a guide for defect analysis (Wilson et al., 2013). Valve defects
were counted based off of observation when compared to the size and morphology of the
wild-type control semilunar valves.

2.11 Compact layer and cross sectional area measurement
Embryos and hearts were processed for paraffin sectioning as described previously.
Sequential transverse sections (5µm) were cut and stained with CAT hematoxylin and
eosin Y for compact layer measurements or subjected to antigen retrieval (described
previously) and incubated with wheat germ agglutinin Alexa Fluor 594 conjugate
(5µg/ml; Invitrogen) to label the cell membranes for cross sectional area measurements.
Compact layer measurements were carried out on Image ProPlus taking the mean of 10
measurements per section on 3 sequential sections per sample. Compact layer was
defined as the region between the outside of the epicardium and beginning of the
trabecular zone. Only sections where all four chambers were visible in transverse
sectioned were used for embryonic compact layer measurements. Adult compact layer
measurements were taken from sections with a visible papillary muscle and
measurements taken from the outside of the epicardium to the beginning of the trabecular
zone. Blinded cross-sectional area measurements of adult mouse hearts were performed
on AxioVision 4.7.1. Forty measurements were made per section on 3 sequential
sections per sample and averaged. Cells were measured only if they had completely
labeled membranes for visualization and a centrally located nucleus. To standardize

31

where cardiomyocyte measurements were taken, only sections where the papillary
muscle was visible were used.

2.12 Proliferation assay
Cryosections (10µm) of E9.5 hearts of all three genotypes were incubated with the
primary antibody against phosphorylated histone H3 (1:500; Cell Signaling) to identify
cells undergoing mitosis. Positive stained nuclei in the left ventricle were counted per
field of view on every fifth section over the entire span of the primitive ventricle. Means
were reported relative to the wild-type embryo. Only cells in the myocardium (both
trabecular and compact layer) cells were counted and were distinguished from the
epicardial and endocardial cells by their location and morphology.

2.13 in utero Ultrasound
Pregnant dams were anaesthetized using isofluorane and prepared for ultrasound. Twodimensional images of the E18.5 embryonic hearts were obtained in B-mode using the
apical four chamber view of the Vevo 2100 high resolution ultrasound digital imaging
platform (Visual Sonics, Canada). Use of color Doppler imaging allowed for the
visualization of speed and direction of blood flow and could thus detect improper blood
flow between the ventricles. Left ventricle (LV) wall thickness, ejection fraction and
fractional shortening were determined by the Visualsonics software using measurements
made with M-mode imaging. The LV internal end-diastolic dimension (LVIDd) and LV
internal systolic dimension (LVIDs) were measured from recordings. Ejection fraction of
the left ventricle was calculated using the values obtained as EF % =

!"#$%! !!"#$%!
!"#$%!

×

100. Fractional shortening was calculated using the values obtained as FS % =
!"#$%!!"#$%
!"#$%

×100. Measurements were averaged from 3 cardiac cycles.

2.14 Statistical Analyses
One way ANOVA was used to assess the statistical significance of differences between
embryonic measurements from all genotypes for compact layer thickness, proliferation
assays and all in utero measurements, with a post-hoc Tukey's test. P < 0.05 was
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considered significant. An unpaired two-tailed Students t-test was used to determine
statistical significance for compact layer and cross-sectional area measurements in adult
mice. P<0.05 was considered significant. All statistical analysis was performed using
GraphPad Prism software 6.0.

33

Chapter 3

3

Results

3.1 Phenotype of the Shroom3 mutant mouse line
The Shroom3 gene trap mouse line used in my study was first described by Hildebrand
and Soriano (1999). The original mutant line was characterized by the fully penetrant
exencephaly (100%). Mice homozygous for the Shroom3 gene trap also exhibited
craniofacial clefting (87%), spina bifida (23%) and defective ventral closure (12%). A
small number of the heterozygotes also displayed the exencephaly phenotype (8%),
although the degree the severity of the neural tube defects was reduced compared to
homozygotes. As expected, our investigation, using the same line, that is now congenic
for C57BL⁄6, shows persistence of the fully penetrant exencephaly phenotype (100%) in
mice homozygous for the gene trap and with 3% (2/60) of heterozygotes afflicted (Fig.
5). Although the heterozygotes appear to show a decreased penetrance of the open neural
tube defects, kinked and curly tails were found in a number of adult heterozygous males
(n=4) suggesting neural tube defects (Henderson et al., 2001; Murdoch et al., 2003).
Differences in the other described defects in the original publication were also noted.
Using stringent criteria for identifying craniofacial clefting, only cleft palates and not
craniofacial deformities were counted and approximately 25% (15/60) of homozygotes
were afflicted. Ventral closure defects were counted when clear herniation of the organs
was observed which was found in approximately 32% (19/60) of the homozygotes. And
lastly, spina bifida was found in approximately 13% (8/60) of homozygotes analyzed.
In addition to the defects noted in the original paper, a series of previously undocumented
phenotypes were noted. Skeletal abnormalities and “eyes open” phenotype were found in
10% (6/60) and 8% (5/60) of embryos observed, respectively. Skeletal abnormalities
were defined as non-fetal like positioning characterized by outstretched forelimb and
hindlimbs and a straightened body when compared to their wild-type littermates. The
“eyes open” phenotype was defined when no observable eyelid covering the eye was
found as compared to the wild-type which showed normal eyelid covering. Generalized
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Figure 5. Shroom3 is essential for neural tube closure. The Shroom3 gene trap
mouse is perinatal lethal due to the completely penetrant exencephaly caused by
neural tube closure failure. A) Wild-type E17.5 embryo displaying a normal
phenotype. B) Shroom3Gt/Gt E17.5 embryo with exencephaly as well as spina bifida
(white arrow), abnormal fetal position and “eyes open” phenotype. Other defects
found in the different mutant embryos were ventral closure failure, facial clefting and
generalized ischemia. Approximately 3% of heterozygotes show the exencephaly
phenotype.
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ischemia, identified as broad paling of the skin, was found in approximately 13% (8/60)
of embryos. These embryos tended to show failure to thrive in utero with obvious
developmental delay compared to their littermates. Taking into consideration that the
mouse model is now backcrossed onto a C57BL⁄6 background, the more pronounced
phenotypes may be attributed to the increased consanguinity of the line compared to that
of the original publication.

3.2 Shroom3 is expressed in the myocardium
To determine when a role for Shroom3 in cardiogenesis might be expected, I examined
when and where Shroom3 is expressed in the heart. Insertion of the lacZ cassette within
the Shroom3 gene allows for the endogenous Shroom3 promoter to control lacZ
expression (Fig. 6). In order to determine the expression pattern of Shroom3, whole
mount X-gal staining of whole embryos (E7.5-E13.5) or excised hearts (E14.5- P8months)
were used as an assay. By whole mount observation, expression throughout the
myocardium of the heart was observed in E10.5-E18.5 embryos (Fig. 7). To control for
any background staining in the assay, matched wild-type controls were stained in parallel
and showed no blue staining was detected. Expression of Shroom3 was detectable
throughout the embryonic myocardium of the ventricles and atria but not in the great
arteries. Expression of the lacZ gene trap was first detected in the heart in E9.5 embryos.
However this could only be visualized in section, as the staining was too weak to be seen
by whole mount (Fig. 8A). Staining was found within the myocardium of the primitive
ventricle but not in the endocardium. Similarly, sections of a stained E14.5 heart
demonstrated that expression of lacZ was restricted to the myocardium of the compact
layer, trabeculae, septum and base of the outflow tracts (Fig. 8B-D). Expression was not
observed in the epicardium, endocardium, endocardial cushions or aortic valve and no
staining was detected in wild type embryos stained for the same amount of time.
In postnatal hearts of newborn and aged mice, lacZ expression was found throughout the
myocardium and base of the outflow tracts, but absent from the great arteries (Fig. 9).
Interestingly, the staining intensity appeared to be higher in the left atrium than the right
atrium in adult mice, suggesting Shroom3 is expressed at higher levels in the left atrium
of adult hearts. Due to heart tissue thickening in the aged hearts, lacZ expression was
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Figure 6. Schematic of the Shroom3 gene trap. Shroom3 was first identified based on a
gene trap insertion that resulted in exencephaly in mouse (Hildebrand and Soriano, 1999).
The inserted lacZ gene cassette was found to be under the control of the endogenous
Shroom3 promoter. The insertion, between exon 3 and exon 4, effectively abolishes any
detectable Shroom3 mRNA long and short isoforms thus preventing any functional
protein from being translated. AA: amino acid; ASD1: Apx⁄Shroom domain 1; ASD2:
Apx⁄Shroom domain 2; Cre: Cre recombinase; pA: polyadenylation sequence; PDZ:
PSD-95⁄Dlg1⁄ZO-1; SA: splice acceptor.
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Figure 7. Shroom3 is expressed throughout cardiogenesis. To detect when Shroom3
+/Gt

was expressed during cardiogenesis, E7.5-E18.5 Shroom3

whole embryos or dissected

hearts were stained for presence of lacZ. In whole mount view, expression was first
observed at E10.5 (A). Widespread and consistent expression was detected throughout
the embryonic hearts in the atria and ventricles but not in the outflow tracts (A-I). Wildtype control hearts (left side) were stained in parallel and showed no detectable staining.
LA: left atrium; LV: left ventricle; OFT: outflow tracts; RA: right atrium; RV: right
ventricle.
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Figure 8. Shroom3 is expressed throughout the myocardium during cardiogenesis. In
order to find where Shroom3 is expressed within the heart, paraffin sections (10µm) of
whole mount stained embryos were stained for the presence of lacZ. A) The primitive
ventricle of an E9.5 mouse embryo showed presence of lacZ in the myocardium but not
the endocardium. B-D) Hearts sections of an E14.5 embryo showed widespread staining
in the compact layer myocardium, trabecular myocardium, ventricular septum and the
base of the aorta. No staining was detected in the endocardium, epicardium, aortic valve,
or endocardial cushions suggesting Shroom3 expression is restricted to the myocardium
in the heart. Ao: aorta; e: epicardium; en: endocardium; m: myocardium. Scale bar:
100µm.
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Figure 9. Shroom3 is expressed in the adult mouse heart. To characterize Shroom3
expression in the mouse heart, newborn and adult wild-type and heterozygous hearts
were stained for presence of lacZ. A) Newborn hearts have an expression pattern
similar to that observed in embryonic hearts. B&C) Expression of lacZ in 3 month and
8 month old mice, respectively, showed increased staining in the left atrium compared
to the right atrium. Widespread expression throughout the ventricles appeared to be
consistent with embryonic expression however this was difficult to observe in wholemount. Expression was observed at the base of the outflow tracts. Wild-type control
hearts stained in parallel showed no background staining. LA: left atrium; LV: left
ventricle; OFT: outflow tracts; RA: right atrium; RV: right ventricle.
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difficult to observe in whole mount preparations. However, sections of a stained 8-month
old heart revealed expression in the myocardium similar to the embryonic expression
profile. In contrast to the early embryo, increased staining was observed in the compact
layer of the myocardium compared to the trabeculae (Fig. 10A-B). As found by whole
mount observation, increased staining intensity in the left atrium compared to the right
atrium was also confirmed in section (Fig. 10C-D).

3.3 Ablation of Shroom3 showed no effect on gross
morphology
Given the widespread expression of Shroom3 in the myocardium after E9.5, I looked for
gross morphological defects in the heart associated with the loss of Shroom3. Embryonic
hearts were excised and analyzed for their size, shape and looping direction. At E13.5,
the embryonic heart has completed looping as well as positioning of the chambers. In
addition, atrial septation of the septum primum is complete and ventricular septation has
neared completion. This heart represents a stage where rapid growth, septation and
interior remodeling are taking place and thus was analyzed across the genotypes for
looping direction, structural shape and overall size (Savolainen et al., 2009). No obvious
external morphological abnormalities aside from natural variations were evident in the
hearts between wild-type, heterozygotes and homozygotes for the gene trap when
analyzed in whole mount at E13.5 (n=10) (Fig. 11A-C).
E15.5 hearts, representing a mature embryonic heart, were analyzed next. At this stage,
growth, valve remodeling and compaction of the ventricular walls are occurring and the
general external structure closely resembles that of the prenatal heart (Savolainen et al.,
2009). When comparing between the genotypes, no external morphological abnormalities
were evident at E15.5 (n=7) (Fig. 11D-F). These findings suggest that although Shroom3
was widely expressed throughout the myocardium, it did not appear to play an obvious
role in the external size, shape or looping of the heart.

3.4 Loss of Shroom3 can result in septal defects
Although there was no clear difference in external morphology, I investigated if Shroom3
deficiency altered the interior architecture of the heart. A directed approach was taken to
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Figure 10. Shroom3 is expressed throughout the myocardium postnatally. In order to
detect where expression of Shroom3 in adult hearts, paraffin sections (10µm) of a whole
mount stained for the presence of lacZ in heterozygous 8 month old mouse hearts. A&B)
Transverse sections through the left and right ventricle, respectively, revealed intense
staining in the compact layer myocardium and to a lesser extent the trabeculae. No
staining was seen in the epicardium. C&D) Sagittal sections through the right and left
atrium, respectively, revealed increased staining intensity in the left atrium. No staining
was found within the endocardium or epicardium. ca: coronary artery; e: epicardium; en:
endocardium; m: myocardium; tr: trabeculae.
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Figure 11. Loss of Shroom3 has no effect on gross morphology. Since Shroom3
expression was detected throughout the myocardium, hearts of E13.5 and E15.5 embryos
were dissected and analyzed for their shape, size and looping direction. A-C) Hearts of
E13.5 embryos showed no obvious structural deformities or improper looping across the
genotypes (n=10). D-F) Similarly, hearts of E15.5 embryos showed no structural or
looping errors across the genotypes (n=7).
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identify cardiac defects in the Shroom3 gene trap mouse model. Previous investigations
in mice with deficiencies in ROCK or nonmuscle myosin IIB have revealed cardiac
abnormalities such as cardia bifida, failure to loop and form chambers, failure to
trabeculate, cardiomyocyte binucleation, hypertrophy and ventricular septal defects
(Takeda et al., 2003; Tullio et al., 1997; Wei et al., 2001; Zhao and Rivkees, 2003). Since
Shroom3 has been previously associated with these effectors in other organs systems, I
then investigated Shroom3 deficient mice for similar phenotypes as described in the
aforementioned investigations. In Shroom3Gt/Gt hearts, I did not observe cardia bifida,
failure to loop or form chambers as investigated earlier for gross morphologic defects. In
sections, failure to trabeculate, prematurely binucleated cardiomyocytes and hypertrophy
were also not evident.
Septation of the chambers is essential to ensure proper blood distribution and prevent
mixing of blood between the ventricles and atria. Defects in formation of the septum wall
are a common cause of congenital heart defects of varying severities. Ventricular
septation begins as a luminal extension of the ventricular wall at the site of greatest
convexity early in the primordial ventricles and is completed by E14.5 in mouse
(Savolainen et al., 2009). Ventricular septal defects can be grouped into two categories:
membranous and muscular. Membranous ventricular septal defects are defined to be gaps
in the apical third of the ventricles at a site closer to the AV valves, while muscular
ventricular septal defects are found within the lower, more muscular, part of the septum.
In humans, depending on the size of the defect, these may spontaneously close or require
medical intervention (Minette and Sahn, 2006). To examine for defects in
developmentally mature hearts that have completed septation, embryos were collected
between E16.5-E18.5. Serial sections stained with H&E revealed ventricular septal
defects in 55% of the Shroom3Gt/Gt mice (n=33) (Fig. 12). Both membranous (72%) and
muscular (28%) ventricular septal defects were found (See Appendices). A
phenotypically normal E18.5 heterozygous embryo was found with a membranous
ventricular septal defect suggesting that Shroom3 is required in certain dosages (Table
1).
Using colour Doppler imaging and pulse wave analysis with ultrasound, our histological
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Figure 12. Shroom3 deficiency results in ventricular septal defects. To determine
if Shroom3 mice have CHDs, hearts of E16.5-E18.5 embryos were observed after
being paraffin sectioned (5µm) and stained with H&E. A&D) Transverse sections of
wild-type hearts show an intact ventricular septum between the two ventricles. B)
Transverse section of a Shroom3Gt/Gt heart with a membranous VSD (black arrow),
with magnification to show an otherwise intact tissue morphology (C). E) Transverse
section of a Shroom3Gt/Gt heart with a muscular VSD (black arrow), with
magnification to show an otherwise intact tissue morphology (F). VSD incidence: +/+
- 0/24; +/Gt – 1/24; Gt/Gt - 18/33. LA: left atrium; LV: left ventricle; RA: right
atrium; RV: right ventricle. Scale bar: 100µm.
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Table 1. Incidence of cardiac defects detected in Shroom3+/+, Shroom3+/Gt and
Shroom3Gt/Gt E18.5 embryos
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findings of VSDs were confirmed in utero (n=2/6) at E18.5 (Fig. 13). Backflow during
diastole is suggestive of a ventricular septal defect and although blood shunting could be
visualized between the ventricles, whether these were membranous or muscular defects
could not be determined by ultrasound.

3.5 Loss of Shroom3 can result in semilunar valve defects
Taking advantage of the transversely sectioned histological samples of E18.5 embryos, I
took a broader approach by using direct comparisons to the wild-type hearts to identify if
there were any other cardiac defects. Interestingly, remodeling complications of the
semilunar valves were observed in the homozygous mutant mice despite being derived
from the endocardium that does not express Shroom3 (Hurle et al., 1980). Approximately
15% of Shroom3Gt/Gt embryos had abnormal aortic valves as identified by their
comparison to the wild-type counterparts whereby clear delineation of the cusps was not
evident (n=27). Approximately 26% of Shroom3Gt/Gt embryos showed thick pulmonary
valves when compared to the wild-type (n=27) (Fig. 14, See Appendices). Thick
pulmonary cusps were seen in one of the E18.5 Shroom3+⁄Gt embryos (Table 1). The
finding of valve remodeling defects suggests a linkage between myocardial and
endocardial development that needs to be further explored.

3.6 Loss of Shroom3 results in compact layer deficits
Shroom3 has been shown to use ROCK as one of its main mediators in other organ
systems (Ernst et al., 2012; Nishimura and Takeichi, 2008; Plageman et al., 2011a;
Taylor et al., 2008). When hearts of chick and mouse were treated with Y-27632, a potent
inhibitor of ROCK, a series of cardiac malformations persist including trabeculation
defects in the early, looping heart (Wei et al., 2001; Zhao and Rivkees, 2003). Although
no differences in the trabeculae network between the genotypes were noted, I examined
the compact layer of the myocardium because deficiencies in trabeculation can be
revealed by differences in ventricle wall thickness (Risebro and Riley, 2006). The heart
tube begins as a thin, single layered myocardial tube with an endocardial lining and
epicardial casing (Harvey, 2002). During mouse heart development, the compact layer of
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Figure 13. Ventricular septal defects in Shroom3 deficient embryos can be seen
using in utero ultrasound. To confirm the presence of VSDs in mutant embryos,
E18.5 embryos were analyzed by in utero ultrasound. A) A 2D image of a wild-type
heart imaged in B-mode using the apical four chamber view. B) Pulse wave analysis
depicts normal aortic blood flow during systole seen in a wild-type E18.5 embryo. C)
Using color Doppler (red) revealed blood shunting between the ventricles through a
VSD in the magnified 2D image (dashed white trace) of a Shroom3Gt/Gt heart.D) Pulse
wave imaging of a Shroom3Gt/Gt embryo with a VSD showed characteristic backflow
during diastole (white arrow). n=2/6. LV: left ventricle; RV: right ventricle.
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Figure 14. Shroom3 deficiency affects semilunar valve development. A&E)
Transverse sections of wild-type hearts with normal development of the aortic and
pulmonary valve, respectively with magnifications (B&F). C) Transverse section of a
Gt/Gt

Shroom3

heart at the site of the aortic valve with abnormal cusp formation, seen in

magnification (D). Delineation of the three leaflets of the aortic valve appears
abnormal (black arrow) when compared to the wild-type which shows three clearly
defined leaflets that span the aortic outflow opening. Incidence: +/+ - 0/18; +/Gt –
Gt/Gt

0/18; Gt/Gt - 4/27. G) Transverse section of a Shroom3

heart at the site of the

pulmonary valve with thick pulmonary cusps, seen in magnification (H).Pulmonary
valves were scored as abnormally thick by visual comparison to matched wild-type
controls. . Incidence: +/+ - 0/18; +/Gt – 1/18; Gt/Gt - 7/27. Ao: aorta; AV: aortic
valve; LA: left atrium; LV: left ventricle; PV: pulmonary valve; RA: right atrium; RV:
right ventricle. Scale bar: 100µm.
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the myocardium undergoes expansive proliferation and future ventricle function is
dependent on the wall thickening that results (Harvey, 2002). The trabecular
myocardium forms throughout cardiogenesis but by E14.5 the majority of the trabeculae
have been assimilated to the compact layer of the myocardium by thickening at their
bases and compacting in a process that is not entirely understood (Chen et al., 2009;
Risebro and Riley, 2006).
I observed that in sections, it appeared that the ventricular wall was thinner. To quantify
this observation, serial sections of E16.5-E18.5 embryonic hearts were generated and
stained with H&E. The compact layer was defined as the space between the outside of
the heart (epicardium) and the boundary where the trabecular myocardium begins, as
identified by gaps between the trabeculae. Since no abnormalities in thickness were seen
in the epicardium, using the outer edge of the epicardium served as a control for
measurements as the epicardium-myocardium boundary can be difficult to discern
depending on the quality of the histology. Measurements of the thickness in the left and
right ventricles were compared independently as there are known differences between
them (Rushmer et al., 1953).
Left ventricle compact layer thickness was significantly reduced in the E16.5-E18.5
Shroom3Gt/Gt hearts compared to both the wild-type and heterozygous hearts, except at
E16.5 where there was no significant difference between the Shroom3+/Gt and
Shroom3Gt/Gt hearts. Significantly reduced left ventricle thickness was also found in the
Shroom3+/Gt hearts when compared to the wild-type hearts at E16.5-E18.5 (Fig. 15-17).
Differences in wall thickness were also confirmed by in utero ultrasound using M-mode
on E18.5 embryos (Fig. 18). Although measurement values for the histology and
ultrasound differ due to the way the data was acquired, the ratios of the thickness
differences were maintained thus validating our approach and results. Significant
differences between mutant and control embryos were only found in the highly
muscularized left ventricle wall, while no difference was detected between the right
ventricle wall thicknesses of the embryos. To control for variability in wall thickness,
only transverse sections where all four chambers were visible were used.
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Figure 15. Loss of Shroom3 results in compact layer deficits at E16.5. A&B)
Transverse section of an E16.5 heart demonstrates where measurements were taken
for each heart section in order to compare wall thickness. The compact layer was
defined as the space between the outer epicardium and where the trabeculae begin. C)
Quantification of the thickness of the compact layers showed no significant
differences in the right ventricle across the genotypes (n=3 per group). However, left
ventricle wall thickness was significantly reduced in the Shroom3+⁄Gt (P<0.001) and
Shroom3Gt/Gt (P<0.001) hearts when compared to the wild-type control, but were not
significantly different from each other. ***P<0.001. Error bars represent standard
deviation from the mean. RV: right ventricle; LV: left ventricle. Scale bar: 100µm.
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Figure 16. Loss of Shroom3 results in compact layer deficits at E17.5. A&B)
Transverse section of an E17.5 heart demonstrates where measurements of wall
thickness were taken for each heart section. The compact layer was defined as the
space between the outer epicardium and where the trabeculae begin. C) Quantification
of the thickness of the compact layers showed no significant differences in the right
ventricle thickness across the genotypes (n=3 per group). However, left ventricle wall
thickness was significantly reduced in the Shroom3+⁄Gt (P<0.01) and Shroom3Gt/Gt
(P<0.001) hearts when compared to the wild-type control. Shroom3Gt/Gt hearts were
significantly thinner than the Shroom3+⁄Gt hearts (P<0.05). ***P<0.001, **P<0.01,
*P<0.05. Error bars represent standard deviation from the mean. RV: right ventricle;
LV: left ventricle. Scale bar: 100µm.
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Figure 17. Loss of Shroom3 results in compact layer deficits at E18.5. A&B)
Transverse section of an E18.5 heart demonstrates where measurements of compact
layer thickness were taken for each heart section. The compact layer was defined as
the space between the outer epicardium and where the trabeculae begin. C)
Quantification of the thickness of the compact layers showed no significant
differences in the right ventricle across the genotypes (n=6 per group). However, left
ventricle wall thickness was significantly reduced in the Shroom3+⁄Gt (P<0.01) and
Shroom3Gt/Gt (P<0.001) hearts when compared to the wild-type control embryos.
However, Shroom3Gt/Gt hearts were significantly thinner than the Shroom3+⁄Gt hearts
(P<0.01). ***P<0.001, **P<0.01. Error bars represent standard deviation from the
mean. RV: right ventricle; LV: left ventricle. Scale bar: 100µm.
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Figure 18. Ventricle wall thickness deficits in Shroom3 deficient embryos as
measured using in utero ultrasound. Left ventricle wall thickness was measured
using M-mode during diastole using in utero ultrasound on E18.5 embryos (n=5-7 per
group). Similar to histological findings, left ventricle wall thickness was significantly
reduced in the Shroom3+⁄Gt (P<0.05) and Shroom3Gt/Gt (P<0.001) hearts when
compared to the wild-type control. However, no significant difference in left ventricle
wall thickness was found between Shroom3+⁄Gt and Shroom3Gt/Gt embryos.
***P<0.001, *P<0.05. Error bars represent standard error of the mean. LV: left
ventricle.
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Due to the perinatal lethality of Shroom3Gt/Gt embryos, only wild type and heterozygous
mice could be studied postnatally. Transverse heart sections of three and eight month old
adult female and male mice, respectively (n=3 for each genotype and age group) showed
decreased left ventricle wall thickness in the heterozygotes when compared to the wildtype hearts at both time points (Fig. 19). However, a normal increase in the thickening of
the heart with age was observed in both the heterozygous and wild-type. To control for
variability in wall thickness along the length of the ventricles, only sections where the
papillary muscle was visible were used.

3.7 Decreased compact layer thickness cannot be
explained by proliferation deficiencies
In order to understand the failure of myocardial thickening in the heterozygous and
homozygous Shroom3 gene trap mouse model, I examined the proliferative capacity of
the myocardium in E9.5 hearts as this represents the stage when Shroom3 expression is
first detected. I looked for proliferation within the compact layer and trabecular
myocardium as the majority of wall thickening is due to proliferation in the compact
layer myocardium (Pasumarthi and Field, 2002; Peshkovsky et al., 2011) and we have
shown Shroom3 expression in the myocardium at that stage.
Myocardial compaction first initiates at E10.5 in mouse where the trabecular
myocardium, comprising the majority of the myocardium at that stage, begins to
assimilate into the ventricle walls. By E14.5, the majority of the trabecular myocardium
has compacted into the ventricle walls increasing wall thickness (Risebro and Riley,
2006). Ventricular wall thickening is believed to have two sources, trabecular compaction
and the proliferation within the highly proliferative compact myocardium that is already
present (Pasumarthi and Field, 2002; Peshkovsky et al., 2011). Using phosphorylated
histone H3 as a marker of cells in the M-phase of the cell cycle, cryosections of E9.5
hearts were analyzed before trabecular myocardial compaction initiates (n=3 per group).
Phosphorylated histone H3 positive nuclei were counted in the future left ventricle
myocardium that could be identified by its shape and cell layer location in section. Data
were expressed as means relative to the wild-type (Fig. 20). Although there were clear
differences between the genotypes in the ventricle wall thickness at E16.5-E18.5 hearts,
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Figure 19. Adult heterozygous mice have thinner ventricle walls than control
mice. Three month old female mouse hearts (n=3 per group) and 8 month old male
mouse hearts (n=3 per group) were compared for differences in myocardial wall
thickness in the left ventricle. The compact layer was defined as the space between
the outside of the epicardium and where the trabeculae begin. A-B&D-E) Transverse
sections of wild-type and heterozygous 3 month and 8 months old hearts, respectively,
show significant differences in thickness in the left ventricle. Arrows and lines
indicate where measurements in the left ventricle were taken. C) Quantification of the
thickness of the compact layers of 3 month old hearts showed a significant decrease in
left ventricle wall thickness in the heterozygous mice (P<0.0001) when compared to
the wild-type. F) Quantification of the thickness of the compact layers of 8 month old
hearts showed a significant decrease in left ventricle wall thickness in the
heterozygous mice (P<0.0001) when compared to the wild-type. ****P<0.0001. Error
bars represent standard deviation from the mean. RV: right ventricle; LV: left
ventricle. Scale bar: 250µm.
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Figure 20. Shroom3 deficient hearts do not show decreased proliferation in the
myocardium. To determine the proliferative index in the heart of Shroom3 deficient
embryos (n=3 per group), E9.5 embryos were cryosectioned (10µm) and
immunostained for phosphorylated histone H3 (red) and counterstained with DAPI
(blue). A-C) Representative sections of E9.5 stained hearts for each genotype. D)
Positive nuclei for phosphorylated histone H3 in the myocardium of the future left
ventricle were counted and expressed as a mean relative to wild-type levels. No
significant differences were found between the genotypes. e: epicardium; en:
endocardium; fLV: future left ventricle; m: myocardium.
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no significant difference in phosphorylated histone H3 positive nuclei was found in
section in E9.5 hearts. These data represent a snapshot in time and a look into the
proliferative index across all time points will be essential to conclusively state whether or
not proliferative deficiencies are responsible for the differences in wall thickness.

3.8 Cardiomyocytes are smaller in the postnatal heart of
heterozygous mice
Decreased ventricle wall thickness compromises cardiac function later in life due to
increased hypertrophy of the cardiomyocytes in response to the added stress on the
thinner ventricles, especially in the highly muscularized left ventricle (Jenni et al., 2001).
Therefore, I predicted that cardiomyocyte cross-sectional area would be increased in
accordance with the literature. To test this, I compared left ventricle cardiomyocyte crosssectional area between wild-type and heterozygous adult mice. Eight month old male
mouse hearts were transversely sectioned and stained using wheat germ agglutinin which
marks the cell membranes of the cardiomyocytes by binding to sialic acid and Nacetylglucosaminyl residues (n=3 per group). Cardiomyocyte cross-sectional area was
measured for cells that had a centralized nucleus in order to have a standardized place of
measurement and to control for variation of cross-sectional area along the length
cardiomyocyte (Fig. 21). Unexpectedly, cross-sectional areas of the Shroom3+/Gt left
ventricle cardiomyocytes were significantly smaller than the wild-type control. To ensure
cell sizes were of comparable regions in the heart, only sections in which the papillary
muscle was present were used.

3.9 Shroom3 role in the cytoskeleton
Shroom3 was originally identified as an actin-binding protein capable of inducing apical
constriction and later shown to function by redistributing already present cytoskeletal
components, such as γ-tubulin, actin, ROCK, nonmuscle myosin IIB as well as a variety
of other cytoskeletal associating proteins (Chung et al., 2010; Ernst et al., 2012; Grosse et
al., 2011; Haigo et al., 2003; Hildebrand, 2005; Hildebrand and Soriano, 1999; Lee et al.,
2007; Nishimura and Takeichi, 2008; Plageman et al., 2010; Plageman et al., 2011a;
Plageman et al., 2011b). In all the developmental systems Shroom3 has been studied in,
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Figure 21. Cardiomyocyte cross-sectional area is smaller in aged heterozygous
mice. Hearts from 8 month old mice (n=3 per genotype) were stained with wheat germ
agglutinin (red) to mark the cell membranes and DAPI (blue) to identify nuclei. A)
Wild-type control heart section showing normal cardiomyocytes in cross section. B)
Cross sectional area views of heterozygous heart. C) Hearts of heterozygous mice
showed a significantly smaller cross-sectional area (P<0.0001) when compared to the
wild-type. Only cells where a centralized nucleus was present were used for
measurements. ****P<0.0001. Error bars represent standard deviation from the mean.
Scale bar: 50µm.
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changes in the actin and/or microtubule cytoskeletons have been noted in mainly
polarized epithelial cells. Therefore, I sought to investigate if there were changes in the
distribution of actin, microtubules and nonmuscle myosin IIB in Shroom3 gene trap
hearts in similar fashion. Since the cytoskeleton of the early heart in mammals has not
been well characterized, I immunostained the neural tube of wild-type and Shroom3Gt/Gt
embryos to serve as a control for our ability to detect changes in the cytoskeleton as
cytoskeletal changes in Shroom3 deficient neural tubes are well documented (Fig. 22)
(Haigo et al., 2003; Hildebrand and Soriano, 1999; Lee et al., 2007). As expected,
Shroom3 is expressed in the median hinge point cells of the neural tube of E9.5 embryos
(Fig. 22A), as shown by the lacZ reporter staining. Using aPKCζ,, demarcation of the
apical surface of the neural tube is revealed which is towards the lumen (Fig. 22B). Loss
of Shroom3 in the neural tube results in decreased apical accumulation of actin, failure to
form parallel microtubule arrays and a decreased accumulation of apical nonmuscle
myosin IIB (Fig. 22C-H). These results are consistent with previous investigations of
Shroom3 function in the neural epithelia and reconfirm the use of our model in studying
Shroom3 function (Haigo et al., 2003; Hildebrand, 2005; Hildebrand and Soriano, 1999;
Lee et al., 2007).Using aPKCζ as a marker for apical-basal polarity; I investigated the
polarity of the early heart tube of E9.5 embryos. Since Shroom3 is found to function in
already polarized cells, understanding what cells have this polarity was essential. At E9.5,
the heart tube is still one cell layer thick, thus making it a simple model when looking for
apical-basal polarity. As seen in Figure 23, there does not appear to be a defined apicalbasal polarity established in the myocardium at this stage. Apical-basal polarity of the
forming heart tube has been shown in Xenopus and chick, whereby the outside of the
heart tube is apical, making it a unique system compared to other tubulogenic events in
development where cell surfaces adjacent to the lumen are generally apical (Grover,
2009; Hogan and Kolodziej, 2002; Peng et al., 1990). In agreement with my observations,
recent studies on mouse heart development, suggests that the mouse heart does not act in
a typical epithelial manner and so apical-basal polarity is normally not observed (Le
Garrec et al., 2013).
Little is known about the role of the cytoskeleton in cardiac morphogenesis in mammals,
however, a number of publications have suggested it is important in looping during chick
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Figure 22. Shroom3 alters the cytoskeletal architecture in the neural tube. Using
the neural tube as a control for known Shroom3 activity altering cytoskeletal
Gt/Gt

architecture, E9.5 wild-type and Shroom3

embryos were stained using

immunocytochemistry for actin, β-tubulin and nonmuscle myosin IIB. A) Transverse
paraffin section (10µm) of a stained E9.5 embryo showed lacZ expression in the
median hinge point cells of the neural tube. B) aPKCζ (green) localization to the apical
surface (towards the lumen) of the neural tube was normal. C&E&G) Wild-type
neural tubes of E9.5 embryos showed normal apical accumulation of actin (green),
parallel arrays of β-tubulin (green) and apical accumulation of nonmuscle myosin IIB
(red). D&F&H) Conversely, loss of apically accumulated actin and nonmuscle myosin
IIB was found in Shroom3

Gt/Gt

neural tubes. Failure to form parallel microtubule

arrays is indicative of failure to undergo apical-basal elongation in the neuroepithelia.
Scale bar: 50µm.
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Figure 23. The early heart tube shows no apical-basal polarity. To determine
where apical-basal polarity in the heart exists and thus where we would expect
Shroom3 to function, E9.5 hearts were immunostained for aPKCζ (green) and DAPI
(blue) to demarcate the apical surface of myocardial cells. A) No localization of
aPKCζ was observed within the myocardium. However, magnification shows the
epicardium with apical-basal polarity as expected (B). e: epicardium; en:
endocardium; m: myocardium. Scale bar: 100µm.
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and rat heart morphogenesis (Itasaki et al., 1991; Latacha et al., 2005; Manasek et al.,
1972; Price et al., 1996; Shiraishi et al., 1995). Immunostaining for actin, β-tubulin and
nonmuscle myosin IIB, I looked at the overall cytoskeletal architecture in the Shroom3
deficient hearts as compared to wild-type. At E9.5, no distinct microtubule networks
were observed in the early cardiomyocytes with staining for β-tubulin, and instead
appeared diffusely throughout the cytoplasm (Fig. 24A&C). Similarly, no clear
localization of nonmuscle myosin IIB to a membrane was seen in the wild-type or the
Shroom3Gt/Gt heart (Fig. 24B&D). However, this antibody only probes for the inactive
unphosphorylated nonmuscle myosin IIB and not the phosphorylated form that would be
required to permit apical constriction (Hildebrand, 2005).
Shroom3 contains an ASD1 domain that has been shown to directly interact with F-actin
(Haigo et al., 2003). Looking at the actin network of wild-type and Shroom3Gt/Gt hearts,
no differences were seen in the single layered myocardium or the trabecular ridges that
were forming (Fig. 25). Since these cells do not exhibit apical- basal polarity, I examined
the actin filament arrangements rather than looking for apical-actin accumulation in the
form of apical actin rings and apical stress fibers. However, there appeared to be no
observable differences in actin organization in the cells of the myocardium.
Next, I looked at the compact layers in the hearts of E16.5 embryos. Histological sections
revealed a significant left ventricular compact layer deficit in the heterozygous and
homozygous gene trapped mice when compared to the wild-type. Since there appears to
be no significant difference between the heterozygotes and homozygotes at this point I
wanted to investigate their actin cytoskeletons as I predicted that the Shroom3+/Gt and
Shroom3Gt/Gt would have comparable actin arrangements in the compact layers while
differing from the wild-type. Looking at filament arrangement and organization there did
not appear to be any differences across the genotypes when examining the right and left
ventricles independently (Fig. 26).
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Figure 24. Pattern of nonmuscle myosin IIB and β-tubulin staining is not
different between the wild-type and homozygous gene trapped heart. A&B) In
wild-type E9.5 hearts, β-tubulin expression (green) is diffuse and no microtubule
arrays were apparent. Nonmuscle myosin IIB (red) is uniformly cytoplasmic. C&D)
Gt/Gt

Similar staining patterns were seen in Shroom3

E9.5 embryos. At least in the early

heart tube, β-tubulin and nonmuscle myosin IIB do not appear to be differentially
Gt/Gt

organized between the wild-type and Shroom3

hearts.

endocardium; m: myocardium; blue: DAPI. Scale bar: 100µm.

e: epicardium; en:
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Figure 25. The actin cytoskeleton is not different in the primitive ventricle of
wild-type and Shroom3

Gt/Gt

embryos. The future left ventricle and future right

ventricle were analyzed for any differences in the actin cytoskeleton as assayed by
staining with Oregon Green Phalloidin (green). A) Wild-type control heart section
with magnification of the future right ventricle (B) and future left ventricle (C). D)
Gt/Gt

Heart section of a Shroom3

embryo with magnification of the future right (E) and

left ventricle (F). Although there appeared to be less trabecular myocardium in the
Gt/Gt

Shroom3

future left ventricle, no obvious differences in actin filament

arrangements were seen between the genotypes. e: epicardium; en: endocardium;
fLV: future left ventricle; fRV: future right ventricle; m: myocardium. Scale bar
(A&D): 100µm. Scale bar (B-C, E-F): 50µm.
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Figure 26. Actin filament arrangements in the compact layer of the myocardium
are not different between all three genotypes. Deficits in the thickness of the left
+⁄Gt

ventricle wall were noted in E16.5 hearts of Shroom3

Gt/Gt

and Shroom3

embryos.

To determine if actin disorganization was reason behind the deficit, cryosections
(10µm) of E16.5 hearts were stained with conjugated Oregon Green Phalloidin
(green) and DAPI (blue) to visualize the actin filaments. A) Overview of a wild-type
heart section with magnification of the right ventricle (B) and left ventricle (C)
+⁄Gt

compact layers. In both the Shroom3

(D-F) and Shroom3

Gt/Gt

(G-I) hearts, no

obvious differences were observed in the actin arrangement in the compact
myocardium and trabeculae compared to the wild-type. Scale bar (A&D&G): 200µm.
Scale bar (B-C, E-F,H-I): 50µm.
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3.10 Shroom3 deficient embryos have reduced heart
function
All the cardiac defects observed associated with Shroom3 loss seen in histological
sections support its importance in normal cardiac morphogenesis. However, whether
these defects are substantial enough to affect heart function could not be demonstrated by
histology. Since the Shroom3 deficient mice die at birth, we utilized in utero ultrasound
to study function in the homozygous mutant mice with the prediction that heart function
would be compromised due to the thin left ventricle wall. E18.5 embryos (n=5-7 per
group) were analyzed for left ventricle fractional shortening and ejection fraction (Fig.
27). Left ventricle fractional shortening was significantly lower in the Shroom3Gt/Gt when
compared to wild-type littermates. Left ventricle ejection fraction also showed a
significant decrease of approximately 25% in the Shroom3Gt/Gt embryos. No significant
difference in the heart functions of heterozygous embryos was detected. These results
demonstrate that Shroom3Gt/Gt mice have significantly impaired cardiac performance at
E18.5.

3.11 ROCK and nonmuscle myosin IIB are required for
Xenopus cardiogenesis
Using Xenopus as an in vivo model, possible downstream effectors of shroom3 were
assessed using pharmacological inhibitors to test if they were required for cardiogenesis
in the same fashion as shroom3 in Xenopus heart development. In previous
investigations, Shroom3 has been shown to act via ROCK, that it actively recruits to the
apical side of the cell where it phosphorylates the regulatory light chain of nonmuscle
myosin II and permits apical constriction (Ernst et al., 2012; Nishimura and Takeichi,
2008; Plageman et al., 2011a). Shroom3 depletion in Xenopus recapitulates what is seen
in the murine model with respect to the failure of neural tube closure; validating the use
of this model to study shroom3 actions. Furthermore, heart defects in shroom3 depleted
Xenopus embryos previously shown in our lab include delayed heart tube formation,
localized edema and subsequent deficiency in proper heart tube looping (Grover, 2009).
Treatment of embryos immediately prior to heart tube closure with Y-27632 and
Rockout, two potent pharmacological small molecule inhibitors of ROCK, resulted in
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Figure 27. Embryos deficient in Shroom3 have compromised heart function in
utero. A) A significant decrease (P<0.05) of 15% in left ventricle fractional shortening
was found in Shroom3Gt/Gt hearts compared to the wild-type embryos as assayed by
measurements taken after diastole and systole. B) When looking at left ventricle
ejection fraction, Shroom3Gt/Gt have a significant (P<0.01) decrease of 25% when
compared to the wild-type embryo. No significant differences were found in
Shroom3+⁄Gt embryos (n=5-7 per group). **P<0.01, *P<0.05. Error bars represent
standard error of the mean. LV: left ventricle.
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Figure 28. Nonmuscle myosin IIB and ROCKII activity is essential for proper
heart tube formation in Xenopus. Embryos were treated with either DMSO, ROCK
or nonmuscle myosin II inhibitors at stage 26 prior to heart tube formation and fixed at
stage 32 when the heart tube begins to close. Using whole-mount in situ hybridization
to stain for the presence of cardiac troponin I mRNA, the forming heart tube is
visualized in ventral view (A-F). Proper heart tube formation was defined by the
presence of flexion points (white arrows) seen in the DMSO control (A').C) Inhibition
of nonmuscle myosin IIB activation by 100µM (-)-blebbistatin results in loss of
flexion points seen in razor section (C'). Controls: DMSO and the inactive enantiomer
(+)-blebbistatin. E-F) Inhibition of ROCK activity by 20µM Rockout or 10µM Y27632 similarly results in loss of flexion points seen in razor sections (E'-F'). Control:
DMSO. G) Quantification of heart tube closure abnormalities was scored by lack of
clearly defined flexion point (seen by razor sections) suggestive of a delay in heart
tube closure and represented as a percentage. Sample sizes are indicated above each
bar.
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Figure 29. Nonmuscle myosin IIB and ROCKII are essential for proper heart
tube looping in Xenopus. Embryos were treated with either DMSO, ROCK or
nonmuscle myosin II inhibitors at stage 26 prior to heart tube formation and fixed at
stage 36 when the heart tube has completed dextral looping. Using whole-mount in
situ hybridization to stain for cardiac troponin I mRNA, the forming heart tube can be
visualized in ventral view (A-F). Proper heart tube looping was defined as the
presence of a clear separation between the atria and ventricle (white arrow) as seen in
the DMSO control (A).B-C) Inhibition of ROCK activity by 20µM Rockout and
10µM Y-27632 and inhibition of nonmuscle myosin IIB activation by 100µM (-)blebbistatin (F) effectively compromised heart tube looping when compared to control
embryos DMSO and the inactive enantiomer (+)-blebbistatin). G) Heart tube looping
abnormalities were scored when a clear boundary between the atria and ventricle
could not be seen in ventral view and represented as a percentage of total embryos.
Sample sizes are indicated above each bar. a: atrium; v: ventricle.
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similar delays in tube closure (Fig. 28D-F) and looping (Fig. 29A-C) as was observed
with shroom3 morpholino and dominant negative mRNA injections. Phosphorylated
nonmuscle myosin II is believed to be the motor protein involved in apical constriction
and tissue morphogenesis downstream of Shroom3 function (Hildebrand, 2005).
Treatment of embryos immediately before heart tube closure with the pharmacological
inhibitor of nonmuscle myosin IIB, blebbistatin, also showed similar cardiac defects to
the phenotype of shroom3 morpholino and dominant negative mRNA injections in
Xenopus. Heart tube formation (Fig. 28A-C) and looping (Fig. 29D-F) were delayed and
abnormal, respectively and were present with pericardial edema, a known indicator of
poor heart function. It is important to note that although these treatments caused heart
tube closure defects, the tubes do eventually close and go on to subsequently loop albeit
with major morphological abnormalities. Although not conclusive, recapitulation of the
phenotype of shroom3 loss by pharmacological intervention suggests that shroom3, at
least in Xenopus heart development, may act through nonmuscle myosin IIB wherein
ROCKII is the primary kinase responsible for its phosphorylation.
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Chapter 4

4

Discussion

Our understanding of congenital heart defects has grown with the identification of
transcription factors, that when mutated, result in morphological defects (Bruneau, 2008;
McCulley and Black, 2012; Teekakirikul et al., 2013). However, a gap in our knowledge
exists whereby downstream effectors of these transcription factors that alter cell
morphology in order to drive morphogenesis remain elusive. In mouse, prior
investigations have shown requirements for transcription factors, the planar cell polarity
pathway as well as cytoskeletal associating proteins for normal cardiac morphogenesis
(Fahed et al., 2013; Henderson and Chaudhry, 2011; Linask and Vanauker, 2007; Wolf
and Basson, 2010). Here, we add Shroom3 to the list as another key regulator of cardiac
development.

4.1 Shroom3 is expressed early in heart development
In Xenopus, shroom3 mRNA is detected well before heart differentiation in the
presumptive heart region as revealed by whole mount in situ hybridization (Drysdale and
Crawford, 1994; Grover, 2009). In mouse, however, expression of Shroom3 in the
developing heart is not observed until E9.5 when heart tube looping is underway and
myocardial differentiation has started. This may be due to differences in cardiac
morphogenesis between Xenopus and mouse. Also, the lacZ assay and in situ
hybridization detect expression in different ways and may have different sensitivities.
Performing an in situ hybridization for Shroom3 mRNA in earlier staged mouse embryos
might be able to reconcile these differences. Alternatively, detection of the protein using
immunocytochemistry in Xenopus may provide more information as to when precisely
Shroom3 is functional in the heart. Antibodies are commercially available but there is no
evidence that the Shroom3 antibodies cross react with Xenopus protein.
Uniform expression of Shroom3 was throughout the atria and ventricles and at the base of
the outflow tracts and the heart expression was restricted to the myocardium at all time
points analyzed. Although expression throughout the myocardium persists postnatally, it
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is important to note that there were differences when compared to the embryonic
expression profile. In the embryonic heart, the myocardium of the compact layer and the
trabecular layer appear to show equal staining suggesting comparable levels of Shroom3
in each. Furthermore, left and right atrial expression appears to be similar in the
embryonic hearts. Expression in the adult mouse heart shows a shift such that increased
staining was observed in the left atrium relative to the right and the compact layer had
greater staining relative to the adjacent trabeculae. In the embryo, trabecular myocardium
is essential for cardiac output as ventricle walls are still relatively thin (Bartman and
Hove, 2005; Risebro and Riley, 2006). However, the adult heart relies heavily on the
thick ventricle walls for contraction (Chen et al., 2009; Risebro and Riley, 2006).
Although I observed no clear differences in trabeculation in mice lacking Shroom3
compared to control hearts, there may be differences. Functional deficits were seen in
utero in the Shroom3Gt/Gt embryos and the reduced wall thickness may be, in part, due to
reduced compaction of the trabeculae.
Adult hearts displayed intense lacZ staining in the left atrium compared to the right
atrium, which was confirmed observing staining intensity in histological sections (Fig.
10). Pitx2 has been shown to play a postnatal role in the conduction system of the heart
and shows a remarkably similar expression profile to that of Shroom3 postnatally with
respect to greater expression in the left atrium compared to the right (Kirchhof et al.,
2011). Pitx transcription factors have been shown to directly activate Shroom3,
suggesting a potential mechanism for the Shroom3 expression differences between the
postnatal atria, Pitx2c is well characterized for its role in left-right asymmetry and is
expressed exclusively on the left side of the lateral plate mesoderm of the embryo
(Schweickert et al., 2000). In the early embryo expression of Shroom3 was found on both
sides of the heart, suggesting that it is unlikely that Pitx2c alone is responsible for its
expression.
The recent association of a missense mutation in SHROOM3 in a human patient with
heterotaxy suggests a role for Shroom3 in the left-right asymmetry and subsequent
looping of the heart (Tariq et al., 2011). However, we did not detect myocardial
expression in the heart until 24 hours after looping initiation by the lacZ gene trap. This
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does not rule out a requirement for Shroom3 during the looping process itself, although
none of the hearts analyzed showed any defects in dextral looping. Since the assay for
Shroom3 expression looked only at the staining of the lacZ gene trap, it could be that
staining intensity was too weak to visualize in earlier heart stages. In this case, use of
whole-mount in situ hybridization for Shroom3 mRNA or use of an antibody to Shroom3
would be beneficial. Furthermore, although I saw no heart looping defects in the mice
this does not mean heterotaxies of other organs were not present. This would need to be
further investigated in future dissections looking at left-right asymmetric organs such as
lungs, gut and spleen. Heterotaxy is a serious and rare congenital heart defect in which
the left-right asymmetries of organs are reversed to varying degrees. Studies on node
morphogenesis have taken precedence in understanding how left-right asymmetry is
achieved with focus on cilia and their angled positioning (Cartwright et al., 2004;
Komatsu and Mishina, 2013; Lee and Anderson, 2008; Nonaka et al., 1998; Nonaka et
al., 2005; Okada et al., 2005). It would be interesting to see if Shroom3 function was
required for the normal positioning of cilia in the node by altering cell morphologies via
apical constriction. Therefore, rather than acting directly on heart tube looping, the role of
Shroom3 on looping direction would be upstream during the symmetry breaking of the
embryo. However, since randomized looping was not observed it suggests that if
Shroom3 function is required, redundancy exists at the node to compensate for loss of
Shroom3 in order to achieve symmetry breaking.

4.2 Shroom3 is required for normal cardiac development
The defects seen with Shroom3 deficiency demonstrate that it is required for proper heart
development. Shroom3Gt/Gt hearts show thinning of the left ventricle myocardium,
ventricular septal defects both membranous and muscular type and semilunar valve
defects. However, how these defects manifest remains unclear. In Xenopus, shroom3
morpholino and dominant negative mRNA injections result in abnormal hearts similar to
isl1 morpholino mRNA injections (Brade et al., 2007; Grover, 2009). However, the
secondary heart field in Xenopus appears normal in shroom3 deficient embryos by whole
mount in situ hybridization for isl1 (Grover, 2009). In our mouse model, the most
dramatic defect is the left ventricle wall thinning. Since left ventricle origin is almost
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entirely first heart field precursors, I believe that, as in Xenopus, the second heart field is
unaffected in Shroom3 deficient embryos (Cai et al., 2003). However this needs to be
further explored by using in situ hybridization or immunofluorescence to detect the
expression of second heart field markers, such as isl1, before any conclusions can be
made regarding differences in the size of the secondary heart field.
While Shroom3 is generally thought to act on the cytoskeleton in a cell autonomous
manner (Ernst et al., 2012; Haigo et al., 2003), it remains possible that the loss of
Shroom3 activity might feedback on the cardiac genetic program. This possibility could
be tested by using qRT-PCR to quantify the mRNA levels of key genes associated with
the cardiac program. As a primary investigation, Gata4, Nkx2.5 mRNA levels would be
of interest as these transcription factors have all been associated with CHDs when
mutated and are part of the early transcriptional program required for normal heart
development (McCulley and Black, 2012). Gata4 is one of the earliest transcription
factors expressed in cardiac cells (E7.0) and is essential for heart tube formation
(Heikinheimo et al., 1994; Kuo et al., 1997; Molkentin et al., 1997). Nkx2.5, like Gata4,
is also expressed early on in the cardiac cells (E7.5) and is essential for cardiac looping
and cardiac differentiation (Lyons et al., 1995). Together, Gata4 and Nkx2.5 act near the
top of the transcriptional cascade controlling a large amount of the cardiac program.
Bmp10, a member of the TGF superfamily of signaling molecules, would also be of
interest to look at given its role in trabecular development and cardiac growth. Loss of
Bmp10 results in thin ventricle walls and failure to normally trabeculate during
development (Chen et al., 2004). Expressed at E9.0, its expression pattern is restricted to
the trabecular zone of the primitive ventricle and later in development to the atrial walls
(Neuhaus et al., 1999). Although I do not expect changes to the cardiac program given
that Shroom3 has been previously shown to be cell autonomous, looking at the
transcriptional network that acts in the myocardium before Shroom3 is expressed in the
heart will give us a preliminary insight to the effects of Shroom3 on the cardiac program,
if any.
Shroom3 has been clearly related to apical basal polarity in the neural tube (Haigo et al.,
2003; Hildebrand, 2005; Hildebrand and Soriano, 1999). However, we found that the
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myocardial epithelium does not appear to show apical-basal polarity (Fig. 23), a finding
suggested in other studies (Le Garrec et al., 2013). Other recent work suggests that the
planar cell polarity pathway appears to be the essential polarizing mechanism in the
murine heart rather than apical-basal polarity (Henderson and Chaudhry, 2011; Le Garrec
et al., 2013). Scrib and Vangl2, two planar cell polarity proteins expressed throughout the
myocardium, have both been associated with cardiovascular defects when mutated
(Henderson et al., 2001; Phillips et al., 2007). Double heterozygotes of Scrib and Vangl2
mutants also show a similar phenotype to the homozygous loss of either individual gene
including open neural tubes, ventral closure defects, “eyes open” phenotype, double
outlet right ventricle, membranous and muscular ventricular septal defects, double sided
aortic arch, overriding aorta, valve defects and ventricular non-compaction (Henderson et
al., 2001; Phillips et al., 2007). The phenotypic similarity to the Shroom3Gt/Gt mice with
respect to neural tube and ventral closure failures and the “eyes open” phenotype makes
this an appealing pathway to investigate to see if there is a relationship between Shroom3
and the planar cell polarity pathway in the heart.
Some of the cardiac malformations seen in planar cell polarity pathway mutants were
also seen in the Shroom3Gt/Gt embryos such as the VSDs, valve defects and ventricular
non-compaction resulting in thin ventricle walls. In Scrib deficient mice, cardiomyocyte
organization is disrupted and there is a loss of N-cadherin in their cell membranes that
has been shown to be essential for normal trabeculation in chick (Ong et al., 1998;
Phillips et al., 2007) providing a potential explanation for the non-compaction of the
ventricles. In order to test whether there is a link between Shroom3 and the planar cell
polarity pathway, investigations into whether cardiomyocyte organization and adhesion
changes observed in the planar cell polarity pathway mutants exist in the Shroom3 gene
trap model should be performed. Cardiomyocyte organization can be analyzed by use of
wheat germ agglutinin to mark cellular membranes. Although I performed wheat germ
agglutinin staining (Fig. 21), I looked at only examined cross sectional views. We now
know that the heart has both regional and local organizations of cardiomyocytes (Le
Garrec et al., 2013). To assess whether organization of the cells has been perturbed would
require using confocal microscopy of marked cardiomyocytes to image successive focal
planes of thicker samples that can be re-assembled into a 3D picture. In addition,
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immunostaining for N-cadherin and ZO-1 would allow for the assessment of
cardiomyocyte adhesion in the Shroom3 gene trap model. In the gut, Shroom3 has been
shown to act with N-cadherin to promote cell shape changes (Plageman et al., 2011b)
suggesting that such an interaction should be tested in the heart.
Surprisingly, abnormal remodeling of the semilunar valves was seen in Shroom3
deficient embryos. This was unexpected as the valves of the heart are endocardial in
origin (Hurle et al., 1980) and Shroom3 expression is restricted to the myocardium and is
believed to act in a cell autonomous fashion (Ernst et al., 2012; Haigo et al., 2003). It
would be of interest to study whether Shroom3 plays a role in promoting EMT during
valvulogenesis and if the defects seen are associated with perturbations in the process.
However, since the defects seen tended to be centered on enlargement of the valves and
their irregular shape, it is suggestive of a problem with the ECM (Wilson et al., 2013).
Defects in the ECM could be assessed by staining for ECM markers such as versican and
collagen.
It is important to point out that two phenotypically normal heterozygous embryos at
E18.5 showed the presence of a membranous VSD or abnormally thick pulmonary cusps
(Table 1). This supports that my findings of cardiac malformations in the Shroom3 gene
trap model are due to the direct loss of Shroom3 in the heart and not because of
confounding factors such as the open neural tube. In addition, there are many mouse
mutants that have neural tube defects but have a normal heart suggesting that a link
between them is unlikely (Copp et al., 2003).
The most consistent cardiac phenotype that I observed was a thin ventricular wall (Fig.
15-17). This was found in both homozygous and heterozygous mutant mice and also in
the heterozygotes in adults. I do not have a mechanistic explanation for the decreased
wall thickness. Deficiencies in proliferation were hypothesized to be the underlying
factor for compact layer deficits rather than apoptosis but no significant differences were
found in proliferation of E9.5 hearts. Shroom3 has been shown to directly interact with
ROCK and both mouse and chick embryos treated with the pharmacological inhibitor of
ROCK, Y-27632, show decreased proliferation in the cardiomyocytes amongst a range of
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other cardiac malformations (Nishimura and Takeichi, 2008; Wei et al., 2001; Zhao and
Rivkees, 2003). A longitudinal analysis across additional time points is required before
we can fully rule out a role for differential proliferation being responsible for the thinner
ventricle walls. In addition, BrdU incorporation may provide a better assessment of the
proliferative capacity of myocardium in the Shroom3 gene trap mouse model. Apoptosis
was also assessed as a potential factor for the decreased wall thickness in the ventricles
and was investigated by staining for activated Caspase-3, however no differences
amongst the genotypes in number of apoptotic cells were found. There appeared to be an
inherent problem in the assay itself as wild-type numbers for apoptotic cells were larger
than what is described in the literature suggesting the protocol used was giving false
positive signals. Using a TUNEL assay in conjunction with staining for activated
Caspase-3 by a different protocol is needed to compare the levels of apoptosis in the
different mouse hearts.

4.3 Shroom3 alters cellular but not cytoskeletal morphology
Shroom3 function has been characterized in a variety of epithelial-based organ systems
where an established apical-basal polarity exists. In the embryo, three major
tubulogenesis events take place at the level of whole organs – heart, neural and gut tube
formation. In both neural and gut tube formation, polarized epithelia are essential for tube
formation and require Shroom3 function (Chung et al., 2010; Haigo et al., 2003;
Hildebrand and Soriano, 1999; Hogan and Kolodziej, 2002). In the mammalian heart,
apical-basal polarity is apparently not required and is instead replaced by the planar cell
polarity pathway that has been shown to be essential for the maintenance and
organization of the multilayered heart (Henderson and Chaudhry, 2011; Le Garrec et al.,
2013). This is different than in zebrafish where disruptions in the apical-basal polarity of
the myocardium in heart and soul and nagie oko mutants disrupt tube formation (Rohr et
al., 2006). Thus, when looking for apical accumulations of actin, nonmuscle myosin IIB,
and apical-basal microtubule arrays in my investigations it is perhaps not surprising that
no clear differences were seen between control and mutant hearts. Therefore, it seems
unlikely that neural tube closure can be used as a model for heart tube closure as the two
systems progress in very different fashions and thus the role for Shroom3 may be quite
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different in the heart compared to the neural tube. It should be noted that Shroom3
function is not limited to apical constriction or apical-basal elongation. In axon
development, Shroom3 has been shown to regulate axon projection development
suggesting its importance in the organization of actin within a cell and not just at the
apical membrane (Dickson et al., 2010; Taylor et al., 2008).
Actin accumulation in discrete regions of the myocardium is essential for cardiac looping
in chick and rat (Itasaki et al., 1991; Latacha et al., 2005; Manasek et al., 1972; Price et
al., 1996; Shiraishi et al., 1995). Although I analyzed serial sections for any distinct
differences in actin accumulation throughout the heart in mutant hearts as compared to
controls, none were seen. Since Shroom3 has been shown to regulate axon outgrowth by
recruitment of F-actin, observable actin projections in the trabeculae and compact
myocardium were assessed for their organization but also showed no obvious differences
(Dickson et al., 2010; Taylor et al., 2008). The heart is a complex 3D structure and in
order to understand the true geometry and arrangements of the cells and their actin
networks, 3D reconstruction is needed. Analysis of hearts in the planar cell polarity
pathway mutants Scrib and Vangl2 suggest that subtle abnormalities in cellular
organization of the early heart tube can manifest into gross morphologic defects
suggesting that obvious differences such as differences in cell number, hypo/hypertrabeculation or other aberrant morphological deficits may not always be seen when
studying cardiac development in mouse models (Henderson et al., 2001; Phillips et al.,
2007). New, high throughput techniques of 3D reconstructions have opened up the
possibilities of analyzing the complex cardiomyocyte organization in the developing
heart (Le Garrec et al., 2013). Despite the lack of differences seen at the cellular level in
section, we cannot rule out that regional and spatial differences may exist in the
Shroom3Gt/Gt hearts that may contribute to cardiac dysmorphogenesis. To test this
hypothesis, 3D reconstruction of the heart showing cardiomyocyte polarity and
organization will be required.
Interestingly, cardiomyocyte cross-sectional area measurements returned unexpected
results. With aging, cardiomyocytes tend to increase in size while surrounding tissues
such as muscle show a decrease in cross-sectional area (Sidhu et al., 2013). Since the
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heterozygous mice display a reduced left ventricle wall thickness, added stress onto the
ventricle chambers would suggest an increase of pathologic ventricle hypertrophy over
time (Sidhu et al., 2013). However, this was not found. Instead, cardiomyocyte crosssectional area was significantly smaller in the Shroom3+/Gt hearts compared to wild-type
hearts taken at similar planar sections of the heart. It appears that Shroom3+ /Gt hearts are
not undergoing the pathologic hypertrophy typically seen with left ventricle wall
thickness deficits. This is consistent with the compact layer measurements of the three
and eight month old adult mouse hearts. Proportional increases in thickness were seen in
the three and eight month old hearts for both genotypes as expected with age. Since the
thickness was not exacerbated in the Shroom3+/Gt hearts of the older mice it suggests that
the ventricle was not undergoing hypertrophy as expected. To follow this finding, in
utero ultrasound would provide a more sensitive analysis of heart function and thickness
than can be seen by histology. Since sex differences do exist in the heart, future
investigations will need to take that into account and although both male and female mice
were used in my investigation of the postnatal phenotype, they were analyzed within the
same gender group to avoid any confounding factors due to sex. Furthermore, although
cardiomyocyte area was measured by way of wheat germ agglutinin to mark the cell
borders, there is a possibility that cardiac fibroblasts were also measured as these sections
were not co-stained for cardiac troponin to mark the cardiomyocytes. However, since
both the wild-type and heterozygous samples were measured in the same fashion we can
conclude there is a difference between the sizes of the cells in the myocardium.

4.4 Shroom3 is required for normal cardiac function
Use of in utero ultrasound allowed me to analyze heart function in Shroom3Gt/Gt hearts
that would otherwise be impossible due to the perinatal lethality of the mutant animals.
Significantly reduced heart function was found in the Shroom3Gt/Gt embryos.
Heterozygotes appear to have normal function with no significant difference in cardiac
output when compared to the wild-type littermates (Fig. 27). The significant functional
deficit in Shroom3Gt/Gt hearts correlates well with the histological findings (Fig. 17).
Significantly thinner left ventricle walls were found in all embryos analyzed and provide
a mechanistic explanation for the functional differences observed. Both ejection fraction
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and fractional shortening are used as measures of cardiac function; however these are
also indirect measures of heart muscularity because they are calculated by measuring the
left ventricle diameters after systole and diastole. Since the Shroom3Gt/Gt hearts show
reduced thickness in their walls, a difference was expected. Since the wall thickness
deficit was persistent throughout the embryonic time points assessed, it would be of value
to assess the heart function in adult mice. Although Shroom3Gt/Gt mice do not survive to
term, heterozygous mice are viable and also demonstrated a significantly reduced left
ventricle wall thickness. Generation of a conditional knockout mouse would be an
important tool to further examine cardiac function in hearts lacking Shroom3; I expect
that heart failure would be seen in mice with loss of Shroom3 because of their thin left
ventricle wall (Jenni et al., 2001). Heart failure was not seen in any of the adult
heterozygous mice in my study. The survival of the mice may be a result of the ventricle
walls being thick enough to sustain the mice or that they were not allowed to live long
enough for manifestation of cardiac failure as no mouse was kept over 8 months of age.

4.5 Xenopus as a model for Shroom3 pathway analysis
Use of Xenopus to study shroom3 function in the heart is a powerful in vivo model.
Embryos are easily accessible and can be treated at discrete time points during
cardiogenesis that is fairly difficult to achieve using murine embryos that cannot be
cultured ex-utero for prolonged periods of time. Use of ROCK and myosin II inhibitors
on embryos when the forming heart tube and cardiac looping is occurring in Xenopus
show a correlation between the defects seen in the shroom3 morpholino and dominant
negative mRNA injections previously done, suggesting a possible functional pathway
(Grover, 2009). Although a phenocopy of the defects was observed in Xenopus, in mouse
loss of ROCK or nonmuscle myosin IIB presents a variety of defects not seen in the
Shroom3 deficient mice (Ma and Adelstein, 2012; Wei et al., 2001; Zhao and Rivkees,
2003). However, heart development is a highly complex process and at least in mammals
the heterogeneity of defects, even those of monogenic origin, remains one of the greatest
complications in understanding how defects manifest.
Our lab has previously shown that shroom3 is required for the thickening of the
myocardium in Xenopus and we have not determined whether myocardial thickening is
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perturbed by inhibition of ROCK and myosin in the developing heart (Grover, 2009).
Shroom3 was found to be transcribed during early heart development, well before cardiac
differentiation (Drysdale and Crawford, 1994; Grover, 2009). What regulates its
expression and why it is required in earlier stages of heart development in Xenopus
remain open questions in need of further investigation. It is important to note that
although cardiogenesis is conserved amongst the vertebrates, differences do exist. In
Xenopus, apical-basal polarity of the single layered myocardium is likely essential for
tube formation and normal cardiac morphogenesis as observed in zebrafish (Grover,
2009; Rohr et al., 2006). Since the murine heart does not appear to require strong apical
basal polarity and is only a single layered epithelium for a short period of time, it is
difficult to assess how results between the two models can be compared.

4.6 Translational relevance for humans
My thesis explores the cardiovascular malformations associated with a complete loss of
Shroom3 and it is important to note that when presented with a non-functional Shroom3
protein, neural tube closure failure is the cause of perinatal lethality. However, there exist
a number of potential human variants of SHROOM3 identified in genome wide
association studies (GWAS) (Bӧger et al., 2011) and by whole-exome sequencing (Tariq
et al., 2011; NHLBI Grand Opportunity Exome Sequencing Project) that are likely
hypomorphic proteins. Since viable heterozygous mice also exhibited a few of the defects
seen with complete loss of Shroom3 (Table 1), they serve as a better model for
understanding the human condition in which SHROOM3 function is likely perturbed and
not completely lost.
In the kidney, several GWAS studies have revealed a SNP associated with SHROOM3 in
patients with albuminuria (Ellis et al., 2012), chronic kidney disease by eGFR function
(Bӧger et al., 2011; Bӧger and Heid, 2011; Kӧttgen et al., 2009; Kӧttgen, 2010; Kӧttgen
et al., 2010), hypomagnesia (Meyer et al., 2010), Type II diabetes (Deshmukh et al.,
2013) and hypertension (Simino et al., 2012). However, there has been no biological data
shown to support these correlations to date. Whole-exome sequencing of a patient with
heterotaxy has also revealed a SNP resulting in a missense mutation (Tariq et al., 2011).
Mining the allele bank supplied by the NHLBI Grand Opportunity Exome Sequencing
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Project gives us an even greater pool of alleles to assess. There appears to be many
mutations found within SHROOM3 and by using Polymorphism Phenotyping program
(PolyPhen2), some of these alleles are predicted to be deleterious. As it stands, there
appears to be a significant amount of polymorphism in SHROOM3 in the human
population which suggests that patients with congenital heart defects associated with
SHROOM3 may in fact be greater than what has been seen.

4.7 Conclusions
Congenital heart defects affect approximately 1% of live births making them the leading
congenital disorder found in newborns with 25% of cases requiring medical intervention
within the first year of life (Hoffman and Kaplan, 2002; Tennant et al., 2010). With
improvements in the medical management of these defects, the number of adults living
with a CHD has increased (Tennant et al., 2010). Although environment plays a
significant role in the manifestation of CHDs, the genetic predisposition still comprises
an important component to causality that must be addressed especially with the increase
of adults living to a reproductive age with these genetic mutations thanks to medical
advances. Our understanding of mutations that affect heart development has come a long
way from the initial characterization of the tinman (Nkx2.5) (Bodmer, 1993; Lyons et al.,
1995). In this investigation, I add Shroom3 to the growing list of genes, that when
mutated, result in CHDs. It is clear from my work and others, that in order to understand
the manifestation of CHDs we must look for linkages between the pathways and factors
already described. Understanding how these pathways work together and whether
compensatory mechanisms exist could help explain the heterogeneity seen in defects of
monogenic origin.
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Appendices

Figure A1. Examples of ventricular septal defects. Examples of ventricular septal
defects seen in the Shroom3Gt/Gt embryos. A-C) muscular VSDs. D-H) membranous
VSDs.
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.

Figure A2. Examples of abnormal aortic valves. Shroom3Gt/Gt embryos show
abnormal aortic valves characterized by the lack of delineation of the three cusps when
compared to the wild-type control.
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.

Figure A3. Examples of thick pulmonary valves. Shroom3Gt/Gt embryos show thick
pulmonary cusps when compared to the wild-type control.
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